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Abstract 
Background: Chronic disease and medication self-management is a life-long process in which patient 
self-efficacy plays an important role in determining success. Efforts to improve self-management have 
traditionally focused on enhancing self-efficacy through medication and disease education, 
development of problem solving skills and decision making. These approaches have been proven to have 
moderate short-term benefits on clinical outcomes while evidence on long-term, post-intervention 
benefits is less convincing. In this project, we were interested in evaluating if patients would find a 
newly developed medication organizing tool (a.k.a. the MedManager) helpful to their medication and 
disease self-management processes. Methods: We conducted a proof-of-concept experiment where 
participants were introduced to the MedManager. A follow-up session was then conducted during which 
utilization of the MedManager was observed. Also during the follow-up session and using a semi-
structured interview format, we explored participant’s perceived barriers in areas of medication therapy 
self-management as well as their perceived advantages of the MedManager in these areas. Quantitative 
and qualitative data obtained were analyzed using descriptive statistics, simple correlation and thematic 
analysis. Results: The MedManager was utilized by a number of our participants at follow-up, primarily 
for its storage function and portability. Interviews with participants revealed a number of perceived 
barriers with existing medication self-management strategies, perceived advantages of the 
MedManager and areas for product improvements. Conclusion: The MedManager were perceived as 
helpful by a number of participants; evidenced by their utilization of the tool at follow-up and the 
perceived advantages of the tool over existing medication self-management strategies expressed during 
interviews. A number of suggestions for product improvement offered by participants can be helpful to 
enhance the MedManager functionality in future versions.  
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Operational Definitions 
The following definitions are used within this paper: 
Chronic Disease Management: Collaborative efforts from patient, family, healthcare team and society to 
reduce impacts of chronic illnesses. 
Chronic Disease Self-Management: Patient’s ability to manage symptoms, treatment, physical, 
psychological and social consequences, and lifestyle changes inherent in living with a chronic condition. 
(Barlow, et al. 2002)21 
Medication Management: An integral component of chronic disease management that “aims to 
optimize therapeutic outcomes for individual patients”. (APhA. 2008) 20 
Usability study: Study that employs participants who are representative of the target population to 
evaluate the degree to which a product meets specific usability criteria (e.g. regarding its usefulness, 
ease of use, learnability or likeability). (Rubin, J. 1994)97 
Usefulness: The degree to which a product enables a user to achieve his or her goals, and is an 
assessment of the user’s motivation for using a product. (Rubin, J. 1994)97 In this project, usefulness is 
assessed by observing actual utilization as well as by exploring user’s rationale/motivation for utilization. 
Utilization: Usage of a product or tool by the user in order to achieve his or her goal. 
Utilization Score: An attempt to quantify the degree of utilization by assigning scores based on each 
component’s utilization status at follow-up. 
xii 
 
Qualitative study: A study that employ qualitative frameworks or methods as primary means to address 
the research question. Examples of qualitative frameworks are Ethnography and Phenomenology; 
examples of qualitative methods are semi-structured interviews, focus groups and thematic analysis. 
Grounded Theory Research: Qualitative research enquiry in which the researcher generates a general 
explanation (a theory) of a process, action, or interaction shaped by the views of participants. (Creswell, 
2003)90 
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SECTION 1: BACKGROUND ON RELEVANT TOPICS 
 
As our project sought to evaluate the usefulness of a product on medication and chronic disease self-
management processes, it was necessary for us to obtain an understanding on relevant topics in these 
areas. This section presents an overview of chronic diseases; followed by a review on common 
approaches to chronic disease management and medication therapy management with a focus on self-
management processes; an overview of medication adherence research; and a discussion on health 
challenges faced by rural residents in Canada. 
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I. CHRONIC DISEASE OVERVIEW 
1.1. Definition, Characteristics and Impacts 
The World Health Organization defines chronic diseases as those “of long duration and generally slow 
progression”.1 Examples of chronic diseases are cardiovascular diseases, chronic respiratory diseases, 
and diabetes. Chronic diseases typically become more common at older age, have a gradual onset and 
progress over time. They can negatively affect quality of life and often necessitate long term 
management.2 
Chronic diseases are the most common and costly of all health problems. In fact, the majority of 
healthcare spending in developed countries is devoted to controlling of chronic diseases and their 
associated risk factors. According to the Center for Disease Control, chronic diseases are responsible for 
more than 75% of total healthcare spending in America.3 The economic impact of chronic illnesses in 
Canada appears to be relatively lower. Nonetheless, more than half (58%) of all annual healthcare 
spending in 2010 was for chronic diseases management and prevention.4 The economic impact of 
chronic diseases goes beyond the healthcare sector. Reported indirect costs associated with loss of 
income and productivity due to chronic illness in Canada was $122 billions in 2010, doubling that of 
direct healthcare costs.4 
 
1.2. Prevalence 
Chronic diseases are common. Data from the 2005 Canadian Community Health Survey showed chronic 
conditions affecting at least one third of all Canadians.5 Chronic disease prevalence also increases with 
age with up to 71% of adults 60 to 79 years of age reportedly having at least one chronic condition. 5 Co-
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morbidity, which is the presence of one or more additional chronic conditions, is also common among 
people with chronic conditions, reportedly affecting nearly half of those 65-79 years of age.5  
Globally, residents of low-income countries are more severely affected by chronic illnesses. Mortality 
rates attributable to chronic diseases were 65%-85% higher in low and middle income countries 
compared to those in high income countries.6 In low and middle income countries, chronic diseases also 
kill at a younger age where 29% of all deaths attributable to chronic diseases occurred among those 
under 60 years old, compared to 13% in high income countries.6 
 
1.3. Risk Factors 
The development of chronic diseases is influenced by a complex interaction of factors. Among these are 
the underlying socio-economic, political, cultural, and environmental aspects of countries. For instance, 
globalization, urbanization and the aging population contribute to the rising incidence of chronic 
diseases because they can lead to unhealthy diets, physical inactivity and tobacco use which increase 
the risks for development of chronic diseases.7  
At the individual level, age and genetics are often implicated in the development of chronic diseases and 
these cannot be modified.7 Unhealthy behaviors, on the other hand, are modifiable and they are the 
main driving force behind the chronic disease epidemic. It has been estimated that up to 80% of 
cardiovascular diseases, strokes and type 2 diabetes as well as over a third of all cancers could be 
prevented by eliminating modifiable risk factors.8 The four most common modifiable risk factors for 
chronic diseases are lack of physical activity, unhealthy diet, tobacco use, and excessive alcohol 
consumption.7,8 The 2011 U.S National Health Interview Survey reported 52% and 76% of adult 
Americans did not meet recommendations for aerobic exercises and muscle-strengthening physical 
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activities respectively, 38% ate fruit less than once a day, and 23% ate vegetables less than once a day. 
Additionally, in 2012 close to one in five U.S adults said they smoked cigarettes and one in six reported 
binge drinking on average once weekly with 8 drinks per binge.3 These numbers suggest the high 
prevalence of unhealthy behaviors in the general population.  
 
1.4. Impacts of Chronic Diseases on Individual, Family and Health Care System 
1.4.1. Individual  
Chronic diseases affect people’s physical and mental health, as well as their social functioning. While 
some individuals with chronic diseases can live full and productive lives, others have to cope with 
isolation, depression, and physical pain as consequences of ongoing chronic illnesses.9 Certain chronic 
conditions such as arthritis can also lead to work disability and consequently reduction in work income.10 
Individuals with co-morbidities are at even greater risks for disability, more likely to be hospitalized, and 
often utilize more health services compared to those with only one chronic condition.9 The psychological 
impact of chronic illness has also been documented. Surveyed Americans cited fear of inability to pay for 
care, loss of independence, and becoming a burden to family and friends as major concerns of having 
chronic illnesses. They also worried about not being able to receive adequate disease and treatment 
information, having trouble accessing needed services, and inadequate quality of care.9 
 
1.4.2. Family and Caregivers 
For people with disabling chronic conditions such as dementia or severe arthritis, family caregivers and 
friends are usually the first line of support to provide daily personal care and help navigating the often 
confusing health care system. Caring for an elderly individual can be burdensome and stressful to many 
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family members.11 A typical caregiver reportedly spends 20.4 hours per week providing care, and 39.3 
hours/week among those who live with their care recipients.12 
The demand and supply trends in family care giving are pulling in opposite directions. The chances of 
becoming a caregiver to someone with a chronic condition are higher today than ever before due to the 
aging population and likely will continue to increase.9 On the other hand, the supply is decreasing due to 
decreasing birth rates, smaller family sizes and smaller family networks.9 People are also marrying and 
having children at later stages in their lives which increases the size of the “sandwich generation”, those 
simultaneously care for their children and their own parents or elderly relatives.9 
 
1.4.3. The Health Care System 
Nolte and McKee suggested chronic diseases affect the health care system in three main areas: Human 
Resources, Decision Support and Financing Structures.13 Managing chronic diseases requires the 
involvement of many healthcare professionals working with patient as team to achieve stated goals.14 
Healthcare professionals would then require an efficient support system (e.g. clinical practice guidelines, 
computerized systems…) to help ensure effective delivery of treatment.14 Lastly, paying for chronic 
conditions management is important and often constitute a major government expenditure in most 
developed countries.9,13 The financing structure of health system has significant implications to the 
nature and quality of services provided.15 Traditional payment structures for institutions and individual 
providers have included fee-for-service, capitation and salary but from the patient point of view, none of 
these methods are seen as fully aligning financial incentives with the goal of providing optimal care.15 In 
contrast, pay-for-performance, which has been defined as “financial incentives that reward providers for 
the achievement of a range of payer objectives”, is an emerging approach to ensure quality and cost-
effectiveness of delivered care.15, 16 
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II. FRAMEWORKS FOR CHRONIC DISEASE MANAGEMENT AND 
MEDICATION THERAPY MANAGEMENT 
 
2.1 The Chronic Care Model 
 
The Chronic Care Model (Wagner, Austin, and Von Korff 1996) represents a common approach to 
chronic disease management within healthcare system by outlining six key components and their roles 
within the chronic disease management process.14 The Model has been refined and widely adopted as 
frameworks for chronic disease prevention and management in the U.S, U.K, Australia, New Zealand and 
Canada.17,18 There is evidence that the Chronic Care Model, when effectively implemented can improve 
outcomes and reduce healthcare costs.19 The roles of each individual component within the Chronic 
Care Model are summarized in Table 1. 
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Table 1: Six Essential Components of Chronic Disease Management 
(Adapted from the Chronic Care Model and the Ontario’s Framework on Preventing and Managing 
Chronic Disease)14,17 
Self-Management Support Self-management support empowers and prepares patients to 
manage their own health while acknowledging the patient’s central 
role in chronic disease management. Self-management support 
strategies include goal-setting, action-planning, problem-solving skills 
and allocating available resources to provide ongoing self-
management support.   
Provider Decision Support Promotes clinical care that is in consistent with current scientific 
evidence and patient preferences. Examples include evidence-based 
practice guidelines embedded into daily clinical practice, ongoing 
provider continuing education, access to specialist expertise and 
routine evaluation of care delivered.  
Delivery System Design 
 
Assures the efficient and effective delivery of care. Improving chronic 
care requires transforming the delivery system from one that is 
essentially reactive (e.g. responding when a person is sick) to one that 
is proactive by focusing on helping people stay as healthy as possible. 
This requires on-going long-term care from an interdisciplinary 
healthcare team working collaboratively with clearly defined roles 
and responsibilities to achieve individualized goals.  
Clinical Information Systems Provides care providers with convenience access to clinical 
information about patients, their care plans and expected outcomes 
in order to facilitate delivery of the best care possible. Examples of 
innovations in clinical information systems include Client Registries 
(allows for patient classification and identification based on certain 
criteria or ICD code), Electronic Health Records, Provider Portals, 
Client Portals, Population Health Data.  
The Health System The Health System should create a culture, organization and 
mechanisms that promote safe, high quality care. Examples include 
offering population-based funding incentives to reward organizations 
or sectors if cholesterol rates fall in the target population or if 
smoking rates drops; implementing outcome-based reimbursement 
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mechanisms; measuring clinician and organization productivity by 
outcomes instead of numbers of visits and technical procedures 
performed to encourage proactive outreach care and alternative 
follow-up structures such as telephone or email interactions with 
patients.  
The Environment/Community 
 
Supportive community recognizes that individuals are more likely to 
be healthy if they live in surroundings that allow them to make 
healthy choices. Supportive social and community environments 
include building social networks to minimize social isolation, foster 
positive family relationships, safe schools and workplaces, create an 
overall sense of security due to low crime rates, and offer programs 
that support people to be healthy.  
 
 
2.2. The Medication Therapy Management (MTM) Service Model 
 
Medication Therapy Management (MTM) is an integral part of chronic disease management and has 
been defined as “A distinct service or group of services that optimize therapeutic outcomes for 
individual patients”.20 Following a patient-centered approach, a main focus of MTM services has been to 
empower patients to take an active role in managing their medications.20 The American Pharmacist 
Association and National Association of Chain Drug Stores Foundation identified five core elements that 
form a framework for an MTM Service Model in pharmacy practice. These elements are described in 
Table 2.  
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Table 2: Five Core Elements of Medication Therapy Management (Adapted From the APhA MTM Service 
Model)20 
Medication Therapy Review (MTR): Patients should receive an annual comprehensive MTR and 
additional targeted MTRs to address new or ongoing medication-related problem(s). Significant 
events such as important changes in the patient’s medication therapy, changes in the patient’s needs 
or resources, changes in health status or condition, a hospital admission or discharge, an emergency 
department visit, or an admission or discharge from a long-term care or assisted-living facility could 
justify additional comprehensive MTRs. 
Personal medication record (PMR): The PMR is intended to assist patients with medication self-
management. Patient should be encouraged to maintain and update this perpetual document.  
Additionally, patients should be educated to carry the PMR with them at all times and share it at all 
health care visits and admissions to or discharges from institutional settings to help ensure that all 
healthcare professionals are aware of their current medication regimen.  
Medication-related action plan (MAP): The MAP is a patient-centric document containing a list of 
actions for the patient to use in tracking progress for self-management. The patient MAP includes only 
items that the patient can act on that have been agreed to by relevant members of the health care 
team. The MAP helps reinforce a sense of patient empowerment and encourages the patient’s active 
participation in his or her adherence behavior and overall medication therapy management.  
Intervention and referral: These are consultative services to address medication-related problems. 
Interventions may include collaboration with physicians or other healthcare professionals to resolve 
existing or potential medication-related problems or working with the patient directly. 
Documentation and follow-up: Creating and maintaining an ongoing patient-specific record that 
document all provided care in an established standard format (E.g. the SOAP note). Services and 
interventions performed by pharmacists or other healthcare professionals should be documented in a 
manner appropriate for evaluating patient progress and sufficient for billing purposes. 
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III. CHRONIC DISEASE SELF-MANAGEMENT 
3.1 Definition, Tasks and Characteristics 
Chronic Disease Self-Management is an important component of the overall chronic disease 
management process and has been defined as “the individual’s ability to manage symptoms, treatment, 
physical, psychological and social consequences and lifestyle changes inherent in living with a chronic 
condition.”21 
Corbin and Strauss (1988) delineated 3 sets of tasks faced by people with chronic conditions: 1) Medical 
management such as taking medications, changing diet, or self-monitoring clinical parameters; 2) 
Creating and maintaining new meaningful life roles regarding jobs, family and friends; and 3) Coping 
with the anger, fear, frustration, and sadness of having a chronic condition.22 These self-management 
tasks reflect the reality that patients are ultimately responsible for their health, and that health care 
providers should view their relationships with patients that of a partnership where patients should be 
encouraged to contribute to the decision making process.23 
A key determinant of successful chronic disease self-management is self-efficacy, “one’s belief in their 
ability to influence events affecting their lives.”24 High levels of self-efficacy often require sufficient 
knowledge of the chronic conditions and its treatments as without understanding the rationale and 
importance of treatments, patients often fail to implement them.25 Additionally, personal values such as 
positive outlook, accepting responsibility and independently solving problems have been identified as 
helpful in maintaining high levels of self-efficacy and effective self-management of chronic diseases.25 
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3.2 Subsequent Health Behavior Changes following Diagnosis of Chronic Illness 
Performing chronic disease self-management tasks requires behavioral changes and maintenance of the 
established changes. The diagnosis of chronic conditions represents a “wake-up-call”, an opportunity for 
individuals to make lifestyle changes known as secondary prevention. Adopting healthy behaviors 
following the onset of diseases are important because they can lower the risk of recurrence, reduce 
severity of disease, increase functioning, and extend longevity.26 Smoking cessation following acute 
myocardial infarction, for instance, has been shown to reduce risk of a subsequent heart attack by half.27 
The literature, nevertheless, suggested that behavioral changes following chronic disease diagnosis are 
difficult to make and that the majority of individuals newly diagnosed with a chronic conditions did not 
subsequently adopt healthier behaviors.26,28  Furthermore, behavioral changes that are temporary are 
unlikely to have substantial effects and long-term maintenance of established behavioral changes may 
be difficult for patients to achieve.26,29 
 
3.3. Perceived Barriers to Chronic Disease Self-Management 
Only few studies have attempted to characterize patient’s perceived barriers to chronic disease self-
management.30 Commonly reported barriers were lack of knowledge about the condition and plan of 
care,9,25,30 physical limitations caused by chronic conditions,30 feeling of helplessness and 
frustrations,9,25,31 poor physician communication and family support.32 Within the context of medication 
self-management, reported barriers have included complex medication regimens,33 side effects of 
medications,30 and medication adherence difficulty.32 A main limitation seen with the reviewed studies 
is the inconsistent results on identified barriers and their prevalence. Moreover, given the various data 
collection methods used, the subjective nature of the data collected (e.g. through questionnaires) and 
the differing patient baseline characteristics, generalization of any results is difficult.32 Nevertheless, 
12 
 
results obtained from these studies have formed the basis for development of new chronic disease self-
management interventions.31,32  
 
3.4. Health Behavioral Theories 
Health behavioral change theories are attempts to explain why people change (or do not change) their 
health behaviors by establishing determinants to behavioral change. Table 3 summarizes key 
characteristics of common health behavioral change theories and models that have served as theoretical 
basis for development of many health behavioral interventions.34  
Table 3: Characteristics of Common Health Behavioral Change Models and Theories 
Name/Author(s) Underlying principle(s) Stages of Change Determinants to 
Behavioral Change 
Health Belief Model 
(Rosenstock, et al. 
1966) 
Health behavior change 
are based on a rational 
appraisal of the balance 
between the barriers to 
and benefits of 
action.34 
N/a  Perceived Severity 
 Perceived 
Susceptibility 
 Perceived Benefits 
 Perceived Barriers 35 
Theory of Reasoned 
Action (TRA) 
(Fishbein & Ajzen, 
1975) 
Behavior is a function 
of the intention to 
perform that 
behavior.35 Intention is 
in turn influenced by 
personal positive or 
negative beliefs 
(attitude) and 
perceived expectations 
of others (subjective 
norms)34 
N/a  Attitudes 
 Subjective norms 35 
Theory of Planned An extension of TRA. 
Intention is determined 
N/a  Attitudes 
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Behavior 
(Fishbein & Ajzen, 
1975) 
by attitude, subjective 
norm and perception of 
the degree to which 
they are capable of, or 
have control over, 
performing a given 
behavior (perceived 
behavioral control).34 
 Subjective Norm 
 Perceived 
Behavioral Control  
34 
Social Cognitive 
Theory 
(Bandura 1950’s) 
Behavior can be 
explained in terms of 
triadic reciprocity 
between three key 
concepts which 
operate as 
determinants of each 
other: The individual, 
the environment and 
behavior.36 
N/a  Knowledge of health 
risks 
 Benefits of change 
 Self-Efficacy 
 Outcome 
expectations34 
Transtheoretical/ 
Stages of Change 
Model 
(Prochaska & 
DiClemente, 1983) 
Behavioral change 
process consists of a 
number of qualitatively 
different stages. People 
move through these 
stages, typically 
relapsing and revisiting 
earlier stages before 
success. 34 
Five Stages of Change: 
 Precontemplation 
 Contemplation 
 Preparation 
 Action 
 Maintenance 36 
Ten  Processes of 
Change: Consciousness 
raising, dramatic relief, 
self-liberation, social 
liberation, counter 
conditioning, stimulus 
control, self-
reevaluation, 
environmental 
reevaluation, 
reinforcement 
management, helping 
relationship.36 
Health Action Process 
Approach 
(Schawarzer and 
Fuchs, 1996 
The process of health 
behavior change is 
conceived as a 
structured process that 
include intention 
formation, planning 
and action.37 
 Motivational phase 
(Intention-forming 
stage) 
 Volitional phase  
(Planning, action and 
maintenance stages)37 
 Self-Efficacy 
 Outcome 
Expectancies 
 Risk perception 37 
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The Health Belief Model, Theory of Reasoned Action, Theory of Planned Behaviour and Social Cognitive 
Theory are designed to predict behaviors at a single point in time.37 They have been called motivational 
models because of their focus on motivational factors that influences the individual’s decision to 
perform (or not perform) the health behavior in question such as self-efficacy.37 The multi-stage models 
(Transtheoretical Model and Health Action Process Approach) on the other hand viewed the process of 
change as consisting of distinct stages with distinct determinants at each stage.37 
Theories are often utilized as underlying principles to guide program development and 
implementation38 and there is evidence that theoretically-informed programs are more effective in 
changing health behaviors than those that are not theoretically informed.39 Nevertheless, application of 
theories in health behavioral interventions remains challenging due to the number of theories available 
and that they need to be properly interpreted and faithfully implemented within the intervention.40 
 
IV. CHARACTERISTICS OF CURRENT CHRONIC DISEASE SELF-MANAGEMENT 
PROGRAMS - A LITERATURE REVIEW 
 
4.1. Objectives 
We were interested in examining current interventions to enhance chronic disease self-management 
and therefore conducted a literature review on published chronic disease self-management programs. 
The objectives of the literature review were: 1) To understand existing approaches to enhance chronic 
disease self-management and 2) To learn about their effectiveness on clinical outcomes.  
Within the context of this project, we were particularly interested in examining the medication-related 
component of existing self-management programs and therefore only considered programs that had 
included a medication self-management component.  
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4.2. Methodology 
4.2.1. Identification of Literature 
After reviewing library resources on steps to conducting a literature review, we searched PubMed, 
SCOPUS and PsyNet from inception to September 1, 2014 for published chronic disease self-
management programs using the following key words: “Self-Management”, “Program”, “Intervention”, 
“Chronic disease” and “Randomized controlled trial” in title and abstract.  
We input our search queries as followed: 
PubMed: (chronic disease[Title/Abstract] AND self management[Title/Abstract]) AND 
program[Title/Abstract] AND (Clinical Trial[ptyp] AND ("1000/01/01"[PDAT] : 
"2014/09/01"[PDAT]) 
SCOPUS: ( TITLE ( program ) AND TITLE ( self-management ) AND TITLE-ABS-KEY ( chronic disease 
) ) AND ( LIMIT-TO ( DOCTYPE , "ar" ) ) AND ( LIMIT-TO ( EXACTKEYWORD , "Randomized 
controlled trial" ) ) 
PsyINFO: Title: Self Management AND Title: Program AND Abstract: Chronic Disease AND 
Methodology: Treatment Outcome/Clinical Trial 
Each article identified by the search queries was reviewed to determine if it has met our pre-defined 
inclusion criteria. The inclusion criteria were as followed: 1) Be available in fulltext in English at time of 
review, 2) Be a Randomized Control Trial that has a “Usual Care” or “Control” group, 3) Primary 
outcome(s) must be patient-related clinical outcome(s) (e.g. cost analysis and health utility studies were 
excluded), 4) The intervention was specific for chronic disease self-management (e.g. post-hoc analyses 
were excluded), 5) Were conducted in community settings and 6) Must include pharmacologic 
intervention.  
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Prior to this review, my knowledge on chronic disease self-management interventions was limited with 
regards to current approaches and their effectiveness. The literature review was intended to address 
this knowledge gap. With regards to our inclusion criteria, we only included randomized controlled trials 
due to concerns about the inherent methodological limitations with other study designs that could 
prevent us from inferring on the validity of reported results. We also thought the inclusion of a placebo 
or usual care group within randomized controlled trials would allow us to examine the absolute 
effectiveness of the interventions. Furthermore, as findings from the literature review was intended to 
help form the basis for formulating our project methodological approaches, we further limited our 
review to interventions designed exclusively to enhance chronic disease self-management, included a 
medication self-management component and were implemented within community settings (e.g. not 
institutional) because these were also characteristics of the MedManager and our project. Finally, we 
were only interested in reviewing program effectiveness on patient-related outcomes and therefore 
excluded those not stating a patient-related clinical outcome as primary objective (e.g. health utility and 
proof-of-concept studies) 
 
4.2.2. Data Abstraction and Analysis 
Full-text version of each eligible study was reviewed to collect data on a) Study underlying theoretical 
framework (if any), b) Mode of Delivery, c) Intervention details (duration, pharmacologic components, 
non-pharmacologic components) and d) Reported effectiveness on patient-related outcomes. These 
study characteristics were intended to help us understand each study’s approach and effectiveness. 
Collected data was then reviewed to look for common themes regarding underlying theoretical 
frameworks, study designs, and documented effectiveness.  
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4.3. Results 
Figure 1: Summary of review process 
91 Titles Identified 
 
 
 
 
74 Articles Excluded 
 
 
 
 
The search queries identified a total of 91 titles, 18 of which met the eligibility criteria. Key 
characteristics of these studies are summarized in Table 4, followed by an analysis on review findings. 
91 Articles Reviewed 
18 Unique Programs met inclusion criteria 
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Table 4: Key characteristics of reviewed chronic disease self-management programs 
  Theoretical Framework 
and Mode of Delivery 
Intervention Details Pharmacologic-
related intervention 
Clinical Measures and Effectiveness 
1 Preparing Adolescents With 
Chronic Disease for Transition 
to Adult Care: A Technology 
Program 
Huang, et al.  
 
-Social Cognitive Theory 
-2-month intensive Web-
based and text-delivered 
disease management and 
skill-based intervention. 
-Target self-management 
constructs of Monitoring 
disease symptoms, Responding 
to treatment effectiveness, 
Actively working with 
healthcare providers. 
-Education on Self-
assess and respond to 
appropriateness of 
treatment 
-Validated Clinical Scales 
-Intervention group demonstrated significant short-
term (<6 months) improvements on performance 
of disease management tasks, health related self-
efficacy, and patient-initiated communication 
compared with controls.  
-No change in other measures such as disease 
status, functional status, or quality of life in 
treatment group over study period. 
2 Effectiveness of Moving On- 
An Australian designed 
generic self-management 
program for people with a 
chronic illness 
Williams et al.  
-Theory of Self-Efficacy 
and Trans-Theoretical 
Behavior Change Model 
-Seven 3-hour-per-week 
group education sessions, 
delivered by two trained 
facilitators (a health 
professional and a lay 
leader. 
-Group education on Managing 
fatigue, Physical activity, 
Healthy eating, Coping with 
chronic illness, Stress 
management, Relaxation, 
Working with healthcare team, 
Developing and evaluating 
personal action plan and 
getting the most out of 
medications 
-Group education on 
“getting the most out 
of medications”. 
 
-Validated Clinical Scales 
-At 16-week follow-up, there was no significant 
difference between groups in self-efficacy scores, 
self-rated health or health distress scores.  
-No significant difference between or within groups 
in self-management knowledge and stage of 
change of behaviors.  
-Intervention group has higher but nonsignificant  
adjusted physical activity and nutrition scores. 
3 Chronic Disease Self-
Management Program 
(Original) 
Lorig, KR, et al.  
-Self-Efficacy 
-7 weekly group education 
sessions of 2.5 hours 
duration by peer leaders  
-Group Education on: adoption 
of exercise programs; use of 
cognitive symptom 
management techniques, such 
as guided relaxation and 
distraction; nutritional change; 
fatigue and sleep management; 
-Education on 
Medication use. 
-Validated Clinical Scales 
(on Health Status, Health Services Utilization and 
Perceived Self-Efficacy) 
-Improvements in health distress and self-efficacy 
vs. control. Reductions in ambulatory health care 
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use of medications and 
community resources; 
managing the emotions of fear, 
anger and depression; training 
in communication with health 
professionals and others; 
health-related problem-solving; 
and decision making. 
utilization during 2-year period.  
4 Living well: An Intervention 
to Improve Self-Management 
of Medical Illness for 
Individuals With Serious 
Mental Illness 
Goldberg RW, et al.  
-Adaptation of the Original 
CDSMP to better fit 
mentally ill patients. 
-13-session peer-
facilitated group education 
sessions. 60-75 minutes 
each over 13 weeks.  
-Group Education on action 
planning, peer feedback and 
support, modeling, problem 
solving.  
-Application of techniques and 
skills to nutrition, exercise, 
sleep, addictive behaviors, 
coordination of general medical 
and psychiatric services.  
-Education on 
Medication 
management 
 
 
-Validated Clinical Scales 
- Participants were evaluated on attitudinal, 
behavioral, and functional outcomes. Intervention 
group showed significant post-intervention 
improvements across attitudinal (self-efficacy and 
patient activation), behavioral (illness self-
management techniques), and functional (physical 
and emotional well-being and general health 
functioning) outcomes. Attenuation of effect was 
observed for most outcomes at 2 months post-
intervention.  
5 The Health and Recovery 
Peer Program: a peer-led 
intervention to improve 
medical self-management for 
persons with serious mental 
illness 
Druss BG, et al.  
-Adaptation of the Original 
CDSMP, with modifications 
to better suit mental 
patients.  
-Intervention group 
attended 6 group sessions 
led by a mental health 
peer specialist 
-Group Education on: Overview 
of self-management, Exercise 
and physical activity, Pain and 
fatigue management, Healthy 
eating on a limited budget, 
Medication management, 
Finding and working with a 
regular doctor. 
-Development of Action Plan 
-Education on 
Medication 
management 
-Validated Scales and Questionnaires 
-Intervention group had significantly greater 
improvement in patient activation and likelihood of 
using primary provider services as well as non-
significant greater improvements in physical 
HRQOL, physical activity and medication adherence 
at 6-month follow-up.  
6 Perceived control moderated 
the self-efficacy-enhancing 
effects of a chronic illness 
self-management 
-Self-Efficacy. Home-based 
variant of the Chronic 
Disease Self-Management 
Program. 
-Exercising safely, Coping with 
difficult emotions, 
Communicating effectively with 
family and healthcare 
-Medication Use -Validated Scale 
-Only the home-based group showed enhanced 
self-efficacy from chronic illness self-management. 
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intervention 
Jerant A, et al.  
 
-3 groups: Weekly 
interventions provided in 
homes or by telephone vs. 
control over 6 weeks. 
Same content as CDSMP 
but differ in method of 
delivery: (individual vs. 
group setting, no 
professional involvement) 
providers, Relaxation and 
cognitive symptoms 
management techniques. 
The effect is not sustained at 6-month follow-up 
7 A pilot study of telephone 
care management and 
structured disease self-
management groups for 
chronic depression 
Ludman, EJ, et al.  
-Developed partly based 
on experience with phone 
care management and the 
Original CDSMP 
-Four groups: 1) Usual 
care, 2) Usual care plus 
Telephone care 
management (monthly for 
3 months, then as 
needed), 3) Usual care 
plus Telephone care 
management plus Peer-led 
chronic disease self-
management group 
program (on-going bi-
monthly group meetings), 
4) Usual care plus 
Telephone care 
management plus 
Professionally led 
depression psychotherapy 
group program 
(Manualized intervention 
over 10 weeks, followed 
by 6 months of twice 
monthly “booster” 
sessions.  
--Telephone care: Monitor 
treatment quality and 
adherence, decisions support, 
ensure appropriate follow-up 
care. 
-Group education on: Disease-
related goal setting and 
problem solving, Cognitive 
symptom management, 
Communication skills, Use of 
community resources. 
-Cognitive-behavioral therapy 
delivered by a psychologist.  
- Education on 
medication 
adherence, 
management of side 
effects, motivational 
enhancement 
strategies to address 
ambivalence about 
medication use in 
non-adherent 
patients. 
-Validated Scales 
-Unable to detect any differences between groups 
in measured clinical outcomes.  
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8 Evaluation of the chronic 
disease self-management 
program (CDSMP) among 
chronically ill older people in 
the Netherlands 
Elzen, H., et al.  
-Application of the Original 
CDSMP.  
-Intervention consists of 6 
weekly group education 
sessions, each 2.5 hr long 
facilitated by a 
psychologist. 
-Group education on: Exercise, 
Cognitive symptom 
management techniques, 
Information on nutrition, 
Fatigue management, 
Managing emotions, 
Communication, Decision-
making 
-Medication Use -Validated Scales 
-No evidence of short-term or long-term program 
effectiveness on self-efficacy, self-management 
behavior, or health status. 
9 Internet-based chronic 
disease self-management: a 
randomized trial. 
Loriq KR, et al.  
-Web-Based version of the 
Original CDSMP.  
-Internet-based program 
consists of interactive 
web-based instruction 
facilitated by a trained 
peer moderator with 
discussion groups and 
book.  
-Cognitive symptom 
management, Emotion 
management, Physician-patient 
communication, Healthy eating, 
Fatigue management, Action 
planning, Problem solving. 
-Medications 
Overview 
-Validated Scales 
-At 1 year, online participants had improvements in 
health distress, fatigue, pain and shortness of 
breath, and a trend toward improvement in illness 
intrusiveness compared to control. Few significant 
differences in health behaviors at 1 year. No 
changes in health utilization in intervention group. 
1
0 
Evaluation of the chronic 
disease self-management 
program in a Chinese 
population 
Siu, AM, et al.  
-Application of the Original 
CDSMP in Chinese 
population 
-Six 2-hour weekly group 
education with one health 
professional and one lay 
person. 
-Group education on Diet, 
Exercise, Medication, Fitness, 
Emotion management, 
Problem-solving skills, and 
Communication with health 
professionals 
-Medication 
management 
-Validated Scales 
-Intervention group demonstrated significantly 
higher self-efficacy, exercise behavior and 
application of cognitive coping strategies compared 
to control at 1 week post intervention.  
1
1 
A randomized controlled trial 
of a self-management 
program for people with a 
chronic illness from 
Vietnamese, Chinese, Italian 
and Greek backgrounds 
Swerissen H., et al.  
-Application of the Original 
CDSMP in people with 
selected ethnic 
backgrounds in Australia 
-6 weekly group education 
sessions with instruments 
delivered in participant’s 
-Symptom management, 
Problem solving, Emotion 
management, Exercise and 
relaxation, Healthy eating, 
Communication skills. 
-Medication use. -Validated Scales 
-At 6 months, intervention group has significantly 
better outcomes on energy, exercise, symptom 
management, self-efficacy, general health, pain, 
fatigue and health distress. No significant 
improvement on health service utilization.  
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first language.  
1
2 
Chronic disease self-
management program for 
low back pain in the elderly 
Haas, M. et al.  
-Application of the Original 
CDSMP to low back pain 
seniors.  
-109 seniors with chronic 
LBP were randomly 
allocated to the CDSMP or 
a wait-list control group. 
Program included weekly 
2.5 hour sessions for 6 
weeks.  
-Group Education on: General 
principles of chronic conditions; 
overview of self-management 
principles; symptoms; care-
seeking options; community 
resources; exercise; relaxation; 
nutrition; medication and side-
effects; skills building; learning 
from others; sharing with 
others; goal setting; action 
plans; feedback; and problem-
solving 
-Medication Use -Validated Scales 
-No advantage in intervention group in improving 
pain, general health, self-efficacy, and self-care 
attitudes vs. control. Suggested benefits for 
emotional well being, fatigue, functional disability.  
1
3 
Activities of daily living 
function and disability in 
older adults in a randomized 
trial of the health 
enhancement program 
Phelan, EA., et al.  
-Buchner/Wagner model 
of disability 
-201 adults aged 70 years 
and older at a senior 
center were randomized 
to intervention or 
controlled. 
Multi-component 
approach: 
-Individual component: 
Participants meet 
individually with a NP who 
gathered health and risk 
factor information and 
developed a “health action 
plan” tailored to the 
participant’s goals and 
preferences. Had 3 in-
person meetings and 9 
-Education on: Self-
management of chronic 
conditions, physical inactivity, 
depression, and social isolation 
-Addressed use of 
unnecessary 
psychoactive 
medications 
 
-Mailed Questionnaires 
-At 12 months, intervention was more likely vs. 
control to improve Activities of Daily Living (ADL) 
function in those with mild to moderate ADL 
disability. No significant difference in development 
of new ADL disability or on worsening of ADL 
function.  
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calls over 12 months. 
-Group-setting 
component: exercise class, 
chronic disease self-
management class, peer 
support. 
1
4 
Implementation and 
quantitative evaluation of 
chronic disease self-
management programme in 
Shanghai, China: randomized 
controlled trial 
Fu, D, et al.  
-Adaptation of the Original 
CDSMP with content 
modification for cultural 
reasons.  
-Seven 2-2.5 hours group 
education  sessions with 
lay-taught and 
professional-taught 
components 
Group Education and Materials 
on: Exercise; Use of cognitive 
symptom management 
techniques; Nutrition; Fatigue 
and sleep management; Use of 
community resources; Use of 
medications; dealing with the 
emotions of fear, anger, and 
depression; Communication 
with others, including health 
professionals; Problem-solving; 
and Decision-making. 
Education on 
Medication Use 
 
-Validated Scales 
-The intervention improved health behavior, self-
efficacy, and health status and reduced 
hospitalization at 6 months post intervention. 
Chinese lay-leaders was as successful as 
professionals. 
1
5 
The Hepatitis C Self-
Management Program: 
Sustainability of Primary 
Outcomes at 1 Year 
Groess, E.J. et al.  
Bandura’s Social Cognitive 
Model. (increases in 
health-related knowledge 
and the acquisition of 
specific behavior change 
skills within a supportive 
group environment results 
in health behavior 
improvements and 
increased self-efficacy)- 
With adaptations from the 
Original CDSMP with 
added contents specific to 
HCV.  
-Six 2-hour weekly group 
education sessions led by 
HCV-specific disease education, 
Problem solving, Treatment 
decision making, Psychological 
management and 
Communication with healthcare 
providers. 
 Antiviral treatment, 
substance use 
-Validated Clinical Scales 
-Intervention group demonstrated advantage in 
disease knowledge, energy/vitality and Quality of 
Well-being at 12 months. 
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health professionals and 
peer leaders and 
information booklets.  
1
6 
Twelve-month outcomes of 
an Internet-based diabetes 
self-management support 
program 
Glasgow, RE, et al.  
-Social-Ecological Theory 
-Two web-based 
intervention groups + 
Usual care group.  
-First intervention group 
were given access to 
program website that 
allows for goal setting in 
medication adherence, 
physical activity and food 
choices. Participants 
create personalized 
“action plan” at week 6 for 
medication taking, healthy 
eating, and physical 
activity, identified barriers 
to achieving stated goals. 
-Second intervention 
group received follow-up 
phone calls and invitation 
to group sessions.  
-Web-based goal setting, action 
planning and education on 
medication taking, healthy 
eating, and physical activity. 
Two follow-up phone calls and 
three group visit invitations 
were added for second 
intervention group. 
 
-Education, Goal 
setting and action 
plan on Medication 
taking and adherence 
-Validated Clinical Scales 
-Between-group differences were largely non-
significant in most measures of psychological 
outcomes and biological outcomes.  Health 
behavioral outcomes improved significantly in 
intervention groups vs. enhanced usual care at 12 
months on eating habits, fat intake, physical 
activity but not medication adherence. No 
difference between intervention groups.  
1
7 
Randomized controlled trial 
of a Psychoeducation 
program for the Self-
Management of Chronic 
Cardiac Pain 
McGillion, MH, et al.  
-Self-Efficacy Theory-
Adaptation of the Original 
CDSMP with added pain-
related contents 
-Six 2hr weekly sessions by 
a registered nurse in group 
format. 
-Group education to enhance 
self-efficacy, including making 
action plan, cognitive symptom 
management, problem solving, 
Managing Emotional Response, 
Communication.  
-Pain-related content includes: 
Relaxation and stress 
management, symptom 
-Medication review 
(Angina and common 
heart medications) 
-Validated Clinical Scales 
-Statistical improvement in HRQL (Physical 
functioning, General Health, Frequency, Stability of 
Angina pain symptoms) and self-efficacy at 3- 
month follow-up.  
25 
 
monitoring and management, 
medication review, diet, 
emotional management 
1
8 
 
 
Effectiveness of an 
Educational self-
Management program for 
outpatients with chronic 
heart failure 
Otsu, H, Moriyama, M.  
-Based on clinical 
guidelines, previous 
programs, and surveys 
data from CHF patients 
-Six one-on-one monthly 
nurse-directed sessions in 
clinic setting. 
-Education on: Adjust to CHF, 
How to quit smoking, Letter to 
family, Diet and alcohol, Self-
management, Medication 
Administration and Monitoring, 
Activities and Exercises. 
-Medicine 
administration and 
monitoring 
-Clinical outcomes and Validated Clinical Scales.  
-Compliance (Diet, exercise, self-monitoring) and 
BNP levels significantly improved in the 
intervention group vs. control at 6 months. QOL 
significantly improved intervention group vs. 
control at 6, 9, 12 months thought measured 
effects attenuated overtime. 
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4.3.1. Underlying Theoretical Frameworks and Modes of Delivery of Reviewed Programs 
While many reviewed programs did not explicitly cite a guiding health behavioral theory, their stated 
objectives, common approaches, and measurement strategies often reflected a focus on enhancing 
patient’s self-efficacy, that is, to provide patients with knowledge, skills and motivation needed to adopt 
healthy behaviors.42-52,54,55,57 Many programs43-52,54,55,57 were adaptations of the Stanford Chronic Disease 
Self-Management Program (CDSMP) (Lorig, et al.) which in itself was also based mainly on the principles 
of enhancing self-efficacy.48  
The most common Mode of Delivery was in-person group education.42-45,47,48,50-52,54,55 Web-based 41,49,56, 
Telephone-based46,47, and one-on-one interventions6,13,18 as well as material hand-outs15,17 have also 
been utilized, either exclusively or in combination with group education.  
 
4.3.2. Intervention Details, Outcome Measurement Strategies and Documented Effectiveness 
Regardless of Mode of Delivery, efforts to improve chronic disease self-management have traditionally 
been focusing on enhancing patient’s self-efficacy through education on disease knowledge, self-
management skills and decision making techniques.42-52,54,55,57 Many were modified versions of the 
Stanford Chronic Disease Self Management Program (CDSMP) in order to better fit targeted patient 
populations which have included those with specific chronic condition (e.g. Diabetes or Chronic 
Depression)44,45,47,52,55-57 or ethnic background (e.g. Chinese population) by adding disease-specific or 
culturally-relevant education components.50,51,54 As a result, education topics were often seen as similar 
among programs and typically included: Diet and Exercise, Emotional Management, Disease Symptom 
Management, Communication with Healthcare Team, and Medication Management. Education on 
medication management seemed to have only played a small part in the overall interventions and seen 
to have addressed areas such as medication knowledge deficit, medication adherence, side effect 
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management, as well as monitoring and responding to medication effectiveness.47,53,56 Another feature 
seen with identified programs was the focus on enhancing goal-setting and decision making skills (e.g. 
through creation of an Action Plan).42,44,45,49,52,53,56,57 
Most in-person group education sessions have been delivered in weekly intervals for 6-7 weeks, typically 
lasted 2-2.5 hours each and taught by either health professionals or trained peer 
leaders.42,43,44,45,47,48,50,51,52,54,55 Web-based programs often included interactive components such as 
discussion forums with trained moderators,49 or are complemented by interactive approaches such as 
text-based and telephone-based follow-ups or invitations to in-person meetings.41,56 Settings for in-
person programs typically included clinics and community centers though we also came across one 
program that delivered home-based interventions.46 
Program effectiveness was commonly measured by administration of validated clinical scales41-58 to 
capture a variety of outcomes such as perceived health status, quality of life and self-efficacy. The 
majority of reviewed programs were able to demonstrate short-term effectiveness in some outcomes 
while failed to show effectiveness on others. Furthermore, the observed effectiveness often subsided in 
subsequent post-intervention follow-ups.44,58 
 
4.4. Discussion 
4.4.1. Literature Review Limitations 
Our literature review used a very specific search strategy within a limited number of research databases. 
Consequently, the reviewed studies may not have represented all existing approaches to chronic disease 
self-management. Additionally, the review process was conducted primarily by the student researcher. 
The lack of additional researchers in the review process could have reduced the objectivity of data 
collection and interpretation. Nevertheless, the similarities seen in many reviewed programs regarding 
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their underlying theoretical framework, intervention design and relative effectiveness provided us with 
an understanding on common approaches and effectiveness of existing programs. 
 
4.4.2. Limitations and Effectiveness of Existing Chronic Disease Self-Management Interventions 
There were two limitations seen with existing self-management approaches: their short intervention 
period and the group-based format. The group-based format, while in itself can be an advantage (e.g. 
allows for peer-to-peer discussion, more cost-effective compared to one-on-one formats), prevents 
designing of more flexible programs that are customizable to individual self-management needs. 
Additionally, self-management needs can change from time to time and should ideally be addressed by 
an on-going, long-term program.  
Nevertheless, improving patient’s health status through enhancing self-efficacy has proven to be a 
promising approach. This is supported by the short-term improvements on clinical outcomes seen in the 
majority of reviewed programs as well as possible long term post-intervention effects as demonstrated 
in subsequent follow-ups of the Original CDSMP.48 Additionally, innovative modes of delivery such as 
web-based or text-based programs have also been proven to be effective, are low cost alternatives to 
traditional programs, and have the potential to reach a much larger number of patients over a more 
extended period of time. 
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V. EXPANDED LITERATURE REVIEW ON USABILITY AND QUALITATIVE 
STUDIES ON CHRONIC DISEASE SELF-MANAGEMENT 
5.1. Objectives  
In order to include relevant usability studies and qualitative studies on Chronic Disease Self-
management, an expanded literature review on published articles was conducted using the following 
inclusion criteria: 
1) Be original research available in full-text in English at time of review. 2) The primary objective is to 
evaluate an innovative product or tool specifically designed to improve self-management processes -OR- 
Employed qualitative methods as primary mean to address the research question and 3) Conducted in 
community settings (e.g. not institutional settings) 
Study abstracts and full-texts were reviewed to determine if they meet the inclusion criteria. Full-text of 
each eligible study was subsequently reviewed more closely to collect information on a) Tool/program 
description and/or study objectives, b) Methodological approaches (e.g. testing procedures, data 
collection and analysis strategies) and c) Findings.  
 
5.2. Identification of Literature 
Published articles on PubMed, SCOPUS and PsyNet from inception to December 31, 2014 were searched 
using key words: “Self-management”, “Chronic disease” in study title. 
Search queries were input as followed: 
SCOPUS: (TITLE (chronic disease )  AND  TITLE ( self-management ) ) 
 301 studies identified   
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             50 Reviews excluded 
             Conference paper, Note, Editorial, Book chapter, Short Survey, Article 
in Press, Letter, Book: 3 eligible studies included out of 42 
  Clinical trials: 27 eligible studies included out of 209  
PubMed: (chronic disease[Title]) AND self-management[Title] 
 Filters Activated: Filters activated: Clinical Trial, Comparative Study, Evaluation Studies, Journal 
Article, Multicenter Study. 
 144 studies identified  3 additional eligible studies included 
PSYInfo: Title: chronic disease AND Title: self-management 
 101 studies identified  1 additional eligible study included 
Table 5 summaries key characteristics of eligible studies 
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Table 5: Characteristics of Reviewed Usability and Qualitative Studies on Chronic Disease Self-Management 
A. Usability Studies 
  System description Evaluation Procedures  Data Collection and 
Analysis  
Findings  
1 Usability Study 
of a Computer-
Based Self-
Management 
System for 
Older Adults 
with Chronic 
Diseases 
 
(Or, C., Tao, D. 
2012) 
A paper prototype version 
of a computer-based, 
interactive, touch screen 
self-management system 
designed for patient use in 
their homes. The system 
allows patients to assess, 
record, and track their vital 
signs, including weight, 
blood pressure, blood 
glucose level, 
temperature, and oxygen 
saturation. It can also 
remind patients to take 
their prescribed 
medications at 
predetermined times.  
Two parts: 
-Heuristics Evaluation (3 
expert evaluators): Evaluated 
system interfaces for their 
conformity to a set of 26 
human factors design 
heuristics by asking expert 
evaluators to determine 
conformity by responding 
“yes” or “no” to each 
heuristic. 
-End-User Testing (57 
participants): 3 stages: 
 Preparation stage 
(Participant Selection, Task 
Design, and planned Data 
Collection methods). 
 Testing stage: At a 
community center.  
Procedures pilot tested on 
first 7 participants. 
Participants asked to 
perform a set of pre-
determined experimental 
tasks with the think-aloud 
method. Video recorded. 
Field notes from RAs, 
participant feedback on 
-Post-test questionnaires 
using Likert Scale: 
 Satisfaction with the 
interface design 
 Perceived usefulness 
 Perceived ease of use 
 Intention to use 
-Post-test interview on 
participants’ opinions 
about the interface 
design.  
-Performance measures: 
task completion time, task 
incompletion time, 
frequency of error, 
frequency of help.  
-Obtain recommendations 
for System Design 
Modifications 
-Descriptive Statistics and 
Content Analysis of 
collected data. 
-Participants were able 
to perform assigned 
tasks and expressed 
mostly positive 
responses about the 
perceived usability 
measures regarding 
system interface.  
-Revealed a number of 
usability problems 
related to system 
navigation, information 
search and 
interpretation, 
information 
presentation and 
readability. 
-Areas for future 
modifications were 
discussed.  
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difficulties after test 
completion.  
 Follow-up stage: Data 
analyzed using descriptive 
Statistics and simple 
content analysis.  
2 Self-
Management 
support using 
an Internet-
linked tablet 
computer (The 
EDGE 
platform)-
based 
intervention in 
chronic 
obstructive 
pulmonary 
disease: 
Protocol for the 
EDGE-COPD 
RCT 
 
(Farmer, A. et 
al. 2014) 
An Internet-linked tablet-
based intervention 
developed to support 
patients with COPD in 
monitoring their health 
and to provide information 
and education about their 
condition. Components 
included: 
 A daily symptom 
diary consisting of 
a series of 
standard questions 
about symptoms. 
 Bluetooth-enabled 
pulse oximeter 
with finger probe. 
 Questionnaires 
presented  every 4 
weeks 
 Software modules 
to provide 
Personalized plans, 
Education 
information 
Data is transmitted in real 
time to a server and 
-Intervention group: 
Participants provided with a 
tablet computer, given 
instructions on the use of the 
EDGE Platform and an 
information booklet. 
-Participants input clinical 
data daily. Data is reviewed by 
a clinician periodically and 
follow-up phone calls are 
made to participants and HCPs 
if data crosses thresholds.  
 
-Usual care group: No tablet 
computers.  
-Primary outcome is 
quality of life, measured 
by St George’s Respiratory 
Questionnaire for COPD 
patients (SGRQ-C) at 
baseline, 6 months and 12 
months.  
In progress-Results due 
in Sept. 2015.  
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reviewed by a clinician 
periodically. 
3 A Feasibility 
Study of Low 
Income 
Homebound 
Older Adults’ 
Participation in 
an Online 
Chronic Disease 
Self-
Management 
Program 
 
(Choi NG, An S, 
Garcia A., 2014) 
A 6-week long “Better 
Choices, Better Health” 
consists of a password-
protected, dedicated 
website that contains 
Learning Center, 
Discussion Center, Tools, 
Post-Office, Help and Class 
Profile.  
Each week for 6 weeks, older 
participants who are low-
income are asked to log on at 
least three times and 
participate in that week’s 
activities.  
Data on feasibility 
collected by: 
 Observational field notes 
during each in-person 
visit or telephone call 
 Short Evaluation Form 
that participants fill out 
weekly 
 Open-ended 
questionnaires post 
intervention covering the 
participant’s experience, 
perceptions, and 
suggestions.  
-Post intervention 
follow-ups show 
improvement in health 
and self-management 
outcomes per self-
reported scales. 
-Participant qualitative 
feedbacks show high 
satisfactions.  
4 Adaptation of 
the health 
literacy 
universal 
precautions 
toolkits for 
rheumatology 
and cardiology 
– Applications 
for pharmacy 
professionals to 
improve self-
management 
and outcomes 
in patients with 
chronic disease. 
 
Two health literacy toolkits 
focuses on issues related 
to rheumatology and 
cardiology, including 
components such as a 
video using teach back 
method, a rheumatology 
specific guide, medication 
aids and handouts, patient 
education materials for 
HCPs. 
-Testing plan for healthcare 
staff at participating sites 
consisting of 3 milestones: 1) 
Form and Train your health 
Literacy Team, 2) Conduct 
Health Literacy Assessment of 
Your Practice, 3) 
Implementation of Tools.  
 
-Pre and post 
questionnaire/feedback. 
Recorded conference calls 
guided by a structured 
interview at completion of 
each milestone.  
-Questionnaire/feedback 
from post-test forms and 
conference calls.  
-Qualitative and 
quantitative data was 
reviewed by team 
members to determine 
tools with the most 
relevance to pharmacists. 
-Participating 
pharmacists and staff 
had positive experiences 
overall with the toolkits, 
offered suggestions for 
revisions.  
-Identified 5 specific 
tools (out of 22) that 
might be of particular 
interests to pharmacists 
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(Callahan LF., et 
al, 2013) 
5 Application of 
the content 
expert process 
to develop a 
clinically useful 
low-literacy 
Chronic Kidney 
Disease Self-
Management 
Knowledge Tool 
 
(Devraj, R. 
Wallace LS. 
2013) 
An instrument that helps 
clinicians assess patients’ 
knowledge of self-
management behaviors in 
CKD patients. 
Instrument development and 
evaluation by expert panel 
consisting of 16 content 
experts.  7 steps from initial 
item generation and drafting, 
qualitative reviews by content 
experts, cycles of revisions, 
review, revisions, etc. 
-Qualitative Review: 
Electronic mail asking 
identified experts to 
evaluate individual items, 
general perceptions and 
formatting features. 
 
-Quantitative Review: 
3-point scale for each 
item: 1) Essential, 2) 
Useful but not essential, 
3) Not necessary. 
Calculation of Content 
Validity Ratio 
-Final version contains 
the 11 items rated as 
“Essential” by content 
experts. 
6 The South 
Australia Health 
Chronic Disease 
Self-
Management 
Internet Trial 
 
(Loriq, K., et al. 
2013) 
An online CDSMP that is 
similar in content to that 
of the Stanford CDSMP but 
delivered electronically 
using threaded bulletin 
board. 
Participants complete 
baseline, 6-month and 12-
month data on eight health 
status measures, seven 
behaviors, four utilization 
measures, self-efficacy, and 
health care satisfaction. 
-Conveniently sampled 
participants completed 
self-administered 
questionnaires at 
baseline, 6-month and 12-
month utilizing validated 
clinical scales.  
-The online program was 
found to be acceptable 
and useful by 
participants. Appeared 
to decrease symptoms, 
improve health 
behaviors, self-efficacy, 
and reduce healthcare 
utilization up to 1 year.  
7 Usability 
Evaluation of 
an Online, 
tailored Self-
Management 
Intervention for 
Chronic 
Obstructive 
A Web program that 
incorporates eight 
Behavioral Change 
Techniques and allows 
patient to choose between 
different modules: Health 
Risk Appraisal, Smoking 
Cessation, Medication 
-Evaluation sessions took 
place in a lab setting. 
Participants log on, follow 
presented instructions to 
complete the program.  
-Pre-test on one individual. 
-Each participant was asked to 
complete 2 pre-determined 
-Task completion rate, 
completion time, program 
rating. 
-Think-aloud data, 
keystrokes, mouse clicks 
were reviewed. 
-Analysis of markers on 
video recordings, field 
-Areas for improvement 
in all three areas: 
Layout, Navigation and 
Content.  
-Participants found 
program was easy to 
use. -Some behavioral 
change techniques were 
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Pulmonary 
Disease 
Patients 
Incorporating 
Behavioral 
Change 
Techniques 
 
(Voncken-
Brewster, V. et 
al. 2013) 
Adherence and Physical 
Activity. 
tasks (2 modules) and to 
verbalize their thoughts while 
performing the tasks. (think-
aloud method) 
-Screen shots and mouse 
clicks were captured, together 
with verbal and non-verbal 
reactions using a webcam. 
-Participants were interviewed 
about their experiences with 
the tasks after testing.  
notes, semi-structured 
interviews to identify 
problems. 
-Problems were grouped 
into three categories: 
content, layout, 
navigation and classified 
as major problems or 
minor problems.  
-Repeating between 
testing rounds, program 
refinement, and 
subsequent testing until 
no new problems were 
discovered.  
perceived as helpful and 
easy to use, while others 
evoked frustration.  
8 Integrating a 
tailored e-
health self-
management 
application for 
chronic 
obstructive 
pulmonary 
disease patients 
into primary 
care: A pilot 
study. 
 
(Voncken-
Brewster, V. , et 
al., 2014) 
An e-Health application 
with: 
 A Health Risk Appraisal 
Questionnaire 
 Behavior Change 
Modules 
 Feedback messages 
provided to patients 
and quarterly reports to 
nurses.  
Participants receive a 
password to log in to the 
application from home using a 
computer with internet 
access. They also receive 
phone calls from the 
researcher who explains the 
study, gives user instructions, 
and answers questions. 
Follow-up after 1 year.  
-Mixed method approach.  
-Quantitative data: Self-
reported health risk 
appraisal questionnaire, 
medical records and 
validated clinical scales 
pre and post intervention. 
Frequency of use during 
the intervention period.  
-Qualitative data: Semi-
structured interviews with 
patients and practice 
nurses during second half 
of intervention period. 
Questions on influence of 
application on outcomes, 
application use and 
satisfactions, impacts on 
-Patient’s initial interests 
diminished after 
multiple uses. Revealed 
opportunities for 
application 
improvements.  
-Showed that it is 
possible to integrate a 
web-based COPD self-
management application 
into current disease 
management process.  
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the organization of care.  
B. Qualitative Studies 
  Goals/Objectives Program Descriptions Qualitative Methods used Findings (from 
qualitative methods) 
9 Breaking 
barriers to self-
management of 
chronic 
diseases – The 
MaXi project 
 
(Nohr, C., 
Bertelsen, P., 
Kanstrup, AM., 
2009) 
To understand barriers to 
patient’s ability to master 
chronic diseases by means 
of information technology 
-Based on principles of 
Participatory Design and User 
Driven Innovation. “Living lab” 
concept with 3 phases: 
 Cooperation: Selecting 
innovators, evoking 
innovative potential 
 Contextualization: 
Understanding situations, 
staging situations 
(interviews, workshops, 
experiments) 
 Conceptualization: 
Conceptualizing ideas, 
Modeling): Sorting, 
Sketching, Visualizing 
-Qualitative data 
collection through family 
interviews (structured), 
post-cards and PDAs for 
additional data collection 
following interviews. 
-Prototype development 
and testing by participants 
in a “living lab”(utilizing 
participatory design and 
user-driven innovation) 
-The “living lab” and 
participatory design 
provided a safe zone in 
which interactions 
between designers, 
enterprises and users 
can experiment with real 
life situations and 
yielded a richness of 
data adequate for design 
cycles.  
10 Implementation 
and Evaluation 
of the Chronic 
Disease Self-
Management 
Program among 
Chinese 
Immigrant 
Older Adults in 
the U.S 
 
(Wang X., et al. 
2014) 
To evaluate the experience 
Chinese older adults who 
participated in a CDSMP in 
a U.S metro area 
Adaptation of the standard 
Stanford CDSMP (delivered in 
Chinese Mandarin by 
students). 
One focus group session 
at the last workshop. (No 
details mentioned) 
-Participants reported 
increasing in knowledge, 
skills, and confidence in 
the program. 
-Program capability in 
addressing culture 
differences may need 
improvements.  
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11 Exploring 
telemonitoring 
and self-
management 
by patients 
with chronic 
obstructive 
pulmonary 
disease: A 
qualitative 
study 
embedded in a 
randomized 
controlled trial 
 
(Fairbrother, P. 
et al., 2013) 
To explore patient and 
professional views on self-
management within the 
context of telemonitoring 
in chronic obstructive 
pulmonary disease 
No intervention -Purposive sampling of 
COPD patients and HC 
professionals to maximize 
baseline variation. 
-Semi-structured one-on-
one interviews using an 
interview guide, audio 
recorded and transcribed 
verbatim. Interviews were 
conducted until data 
saturation had been 
reached.  
-Data analysis using the 
Framework approach 
consisting of 1) data 
management, 2) 
descriptive accounts, 3) 
explanatory accounts and 
involved multiple reviews 
of transcripts by the 
researcher, coding, 
identifying emergent 
categories and themes 
which then reviewed by 
the research team to 
refine categories and 
themes. Constant 
comparison (e.g. checking 
experiences between 
participants) to help 
ensure the analysis 
represented all 
perspectives.  
-Patients considered 
telemonitoring 
empowered self-
management by 
enhancing their 
understanding of COPD 
and providing 
justification to adjust 
treatment or seek 
professional advice.  
-Professionals discussed 
telemonitoring as 
promoting self-
management but 
concerns about creating 
dependence on HCPs.  
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12 Spanning 
Boundaries into 
Remote 
Communities: 
An Exploration 
of Experiences 
with Telehealth 
Chronic Disease 
Self-
Management 
Programs in 
Rural Northern 
Ontario 
 
(Guilcher, SJ. Et 
al. 2013) 
To explore the experience 
of participants in a chronic 
disease self-management 
program via telehealth to 
inform future tele-CDSMP 
delivery models.  
The Stanford CDSMP delivered 
via telehealth to rural 
communities in Northern 
Ontario.  
-Focus group post-
intervention (minimum of 
6 participants each) to 
explore the overall 
experiences of 
participants and to gain 
understanding of the 
facilitators and barriers of 
telehealth delivery.  
-Researcher triangulation 
(several research team 
members coded 
transcripts independently, 
and analyses are 
compared). 
-Thematic analysis 
consisting of transcript 
coding (dividing texts of 
transcripts into segments 
and attaching descriptive 
coded to these segments), 
grouping codes into topic-
oriented categories, and 
refining topic-oriented 
categories into analytical 
categories (themes).  
-Concurrent data 
collection and data 
analysis to allow for 
confirmation or 
modification of emerging 
themes as new transcripts 
are analyzed. 
-Four final themes 
identified, together with 
key barriers and 
facilitators reported by 
focus group participants. 
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13 Recruitment for 
a clinical trial of 
chronic disease 
self-
management 
for older adults 
with 
multimorbidity: 
A successful 
approach 
within general 
practice 
 
(Reed, R., et al. 
2013) 
To explore reasons for 
participation in a CDSM 
support program.  
Recruitment procedure for 
original study: Eligible 
participants received an 
invitation letter from general 
practices. Letters were signed 
by general practitioners 
endorsing the study, stressing 
the importance of their 
contribution, Prepaid return 
envelopes. Interested 
participants were further 
contacted for recruitment 
after receiving the return 
envelopes.  
-Purposeful sampling of 
past participants between 
and within different strata 
for maximal baseline 
variations.  
-Sampling continued until 
no new information was 
found to emerge from the 
interviews (30 total). 
Interviews were tape 
recorded and transcribed. 
-Thematic analysis of 
transcribed data with 
researcher triangulation 
through team reviews of 
final coding, selection of 
quotes, and emerging 
interpretations.  
Primary reasons for 
participation identified 
were: Altruism, Hope of 
health gains, and 
Recommendation of 
doctors.  
14 Programmes to 
support chronic 
disease self-
management: 
should we be 
concerned 
about the 
impact on 
spouses 
 
(Master, S. et al. 
2013) 
To explore the impacts of 
Chronic Disease Self-
Management Support 
(CDSMS) on Spouses.  
The CDSMS Program is a 
clinician-led intervention 
including 3 home visits and 4 
telephone calls over a 6-
month period.  
-Part of a mixed method 
approach.  
-Semi-structured 
interview with spouses 
using a pilot-tested 
interview guide. Voice 
recorded and transcribed.  
-Copies of transcripts 
were mailed to 
interviewees with a reply 
paid envelope to confirm 
accuracy, clarify meaning 
or expand on topics 
discussed.  
- Spouses were assigned 
-CDSM programs have 
little impact (either 
positive or negative) on 
spousal strains. -Increase 
in spousal strain may 
occur if there is 
deterioration in the 
health status of the 
CDSM participant.  
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to low, moderate or high 
carer risk groups.   Data 
analysis included open 
coding of transcripts; 
identifying themes which 
were discussed at weekly 
meetings there they are 
refined. 
15 Mental health 
and Relational 
Self-
Management 
Experiences of 
Patients with 
Type 2 Diabetes 
and Stage 3 
Chronic Kidney 
Disease  
 
(Sakraida, TJ., 
Robinson MV., 
2012) 
To characterize the 
transition experience to 
self-management in 
patients with T2DM and 
CKD. 
No intervention. Participants 
recruited from endocrine and 
kidney specialty outpatient 
clinics at a medical center in 
the Rocky Mountain region 
who met pre-defined criteria.  
-Convenient sampling, 
ethnography approach.  
-Two focus group sessions 
of the same group, 1 
month apart to allow time 
for preliminary analysis of 
major themes and to 
refine interview guide 
questions to seek more 
thorough data. Utilize 
semi-structured interview 
guide with a moderator 
and two note takers. 
Audio recorded and 
transcribed.  
-Thematic analysis of 
transcripts and field notes. 
-Researcher triangulation 
during coding, developing 
and refining themes.  
-Two major themes 
regarding Mental Health 
Self-Management 
(Coping) and Relational 
Self-Management (Social 
support) 
16 Exploring 
Participation 
and 
Engagement in 
a Study of Self-
To investigate why some 
participants engaged more 
fully than others in a CDSM 
program (the Pathways 
Home Program) 
The PHP is a CDSM program 
for patients with COPD aimed 
to assist patients with 
developing skills in self-
management in the 
Qualitative, interpretative 
study consist of: 
-Purposive sampling to 
ensure diversity in age, 
gender, geographical 
-Motivation to 
participation is based on 
dominant voluntaristic 
or altruistic values, 
which can be 
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Management 
for People with 
Chronic 
Obstructive 
Pulmonary 
Disease 
 
(Willis, KF. et al. 
2011) 
community by facilitating the 
development of self-efficacy 
and provide participants with 
a self-management mentor.  
location and illness 
severity. 
Semi-structured 
interviews, digitally 
recorded and transcribed 
verbatim. 
-Thematic analysis 
consisting of coding of 
transcripts, categorizing, 
and refining emerging 
themes. Alternating data 
collection and data 
analysis (data analyses 
between interviews) to 
allow for comments on 
areas for additional 
investigation or 
clarification. 
problematic for 
researchers attempting 
to demonstrate the 
benefits of CDSM 
strategies.  
17 Chronic disease 
self-
management 
for individuals 
with stroke, 
multiple 
sclerosis and 
spinal cord 
injury 
 
(Sakraida, TJ., 
Robinson, MV., 
2012) 
To explore the experience 
of people with 
neurological conditions 
who take the CDSM 
programme.  
Standard Stanford CDSMP -Semi-structured 
interviews within 1 week 
of completion of CDSM 
workshop using an 
interview guide, tape-
recorded and transcribing 
verbatim. 
-Content analysis 
consisting of identifying 
and refining categories 
and definitions with 
researcher triangulation 
by separate transcript 
coding and subsequent 
team review to reach 
-5 categories emerged 
from interviews that 
might provide insights 
regarding optimal ways 
to present the CDSM 
program to people with 
neurological conditions.  
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consensus on units of 
information. 
-Summary of findings 
mailed to participants 
with subsequent follow-up 
phone calls for 
confirmation of data 
accuracy.  
18 Seeking the 
views of health 
professionals 
on translating 
chronic disease 
self-
management 
models into 
practice 
 
(Lake, AJ., 
Staiger, PK. 
2010) 
To examine health 
professional’s formal self-
management training and 
their views and 
experiences on the use of 
self-management 
techniques when working 
with people with a chronic 
illness 
No intervention -Purposive sample 
included a wide range of 
stakeholders involved in 
the care of individuals 
with a CD across 
professional disciplines.  
-Semi-structured 
interviews in both 
individual and group 
format, audio-taped and 
transcribed.  
-Thematic analysis 
consisting of coding, 
defining emerged 
categories and themes 
and researcher 
triangulation through 
consensus on emerging 
themes.  
-Ensure credibility, for 
example, by leaving an 
audit trail.  
Professional preference 
for a “comprehensive” 
approach to self-
management, relying 
primarily on 5 identified 
elements. 
-Revealed some central 
problems associated 
with CDSM regarding 
medication management 
or limited efficacy with 
some patient groups.  
 
19 Chronic Disease 
Self-
Management: 
To understand how 
Chinese culture influences 
chronic disease self-
No intervention -Qualitative descriptive 
study using focus group 
methodology 
6 themes identified. 
Findings suggested older 
Chinese tend to make 
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Views Among 
Older Adults of 
Chinese 
Descent 
 
(Wang, J., 
Matthews, JT. 
2010) 
management -Recruitment by flyers in 
monthly newsletter and 
reception area of a senior 
center. 
-Two unique focus groups, 
1 week apart using semi-
structured schedule of 
questions, audio-taped. 
Transcribed in Chinese, 
then translated in English. 
Transcripts were reviewed 
by more than one 
facilitator.  
-Data analysis consisting 
of coding of responses, 
creating categories and 
identifying recurring 
themes.  
healthy lifestyle 
decisions and view self-
management of chronic 
disease as integral to 
everyday life. They also 
show strong influence of 
Chinese culture 
throughout all aspect of 
daily life. And difficulties 
communicating with 
HCPs may hamper 
efforts to optimize 
health.  
20 Evaluation of a 
rural chronic 
disease self-
management 
program 
 
(Stone, GR., 
Packer, Tl. 2010) 
To evaluate the 
implementation process of 
the Stanford CDSMP into 
existing practice in an 
Australian rural setting.  
Standard Stanford CDSMP -Participants were 
recruited by letters of 
invitation.  
-Semi-structured 
interviews with managers, 
course leaders and 
participants, subsequently 
audio-recorded and 
transcribed.  
-Thematic analysis to 
identify emergent themes 
as well as positive and 
negative perceptions of 
the program. 
-Positives and negatives 
of providing the program 
were represented by 
two identified key 
themes: a) Program 
content and quality and 
b) Logistics of delivery 
-Recommendations by 
participants were 
grouped into 3 
categories: (enhancing 
quality, improving 
logistics, and providing 
resources.) 
21 The experience To examine the perceived Standard Stanford CDSMP -Qualitative study nested -3 themes identified at 
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of attending a 
lay-led, chronic 
disease self-
management 
programme 
from the 
perspective of 
participants 
with multiple 
sclerosis 
 
(Barlow, J. 
Edward, R., 
Turner, A. 2009) 
value and experience of 
the CDSMP for people with 
MS 
in a RCT. Study 
participants were 
purposively selected to 
ensure a range of ages 
and disease duration.  
-Telephone interviews of 
enrolled participants by 
two researchers at 
enrolment of CDSMP and 
4 month follow-up on pre-
determined subjects 
related to the program. 
Interviews were tape-
recorded and transcribed 
verbatim.  
-Framework analysis (with 
pre-identified themes but 
allows for new themes to 
emerge from the data). 
baseline, and 4 themes 
identified at follow-up.  
-The CDSMC was viewed 
as a valuable source of 
new skills and a 
reminder of previously 
learned self-
management skills.  
22 Understanding 
metaphor to 
facilitate 
emotional 
expression 
during a chronic 
disease self-
management 
course 
 
(McFarland, L., 
Barlow, J., 
Turner, A., 
2009).  
To investigate the role of 
emotional expression by 
identifying , from the 
perspective of the tutors, 
the emotions observed in 
people attending a 
CDSMC.  
Standard Stanford CDSMP -Recruitment through 
emails to tutors who 
recently completed 
delivery of the CDSMC. 
-Semi-structured 
interviews with tutors, 
digitally recorded and 
transcribed verbatim.  
Interpretive 
phenomenological 
analysis (Offers insights 
into how a given person, 
in a given context, makes 
sense of a given 
Two main themes: 
Metaphor and Off-
loading. Results could be 
applied to training of 
CDSMP tutors.  
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phenomenon) including 
data familiarization, 
identifying relevant 
themes and refining 
themes.  
-Researcher triangulation 
through transcript cross-
examination and 
verification of each 
other’s findings.  
23 Health Literacy 
Self-
Management 
by Patients 
with Type 2 
Diabetes and 
Stage 3 Chronic 
Kidney Disease 
 
(Sakraida, TJ., 
Robinson, MV. 
2009) 
To describe self-
management experience 
of patients diagnosed with 
type 2 diabetes and stage 
3 CKD 
No intervention -Ethnography approach 
(to understand the illness 
experiences of select 
populations). 
-Purposive sampling to 
establish a focus group 
with different subsets of 
potentially contrasting 
and common viewpoints. -
-Semi-structured focus 
group interviews and 
observation field notes.  
Two focus group sessions 
of the same group, 
scheduled 4 weeks apart 
to allow time for initial 
analysis and modification 
of questions.  
-Focus group meetings 
were transcribed and 
audited. Coding of 
clustered sentences, 
identifying and label 
Two major threads of 
self-management 
experience identified: a) 
transition experience to 
self-advocacy and b) 
partnering with the 
health care provider.  
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patterns and themes.  
-Multiple rounds of 
transcript review led to 
pattern redundancy and 
no new discernible 
themes supported 
conclusion of data 
analysis. 
-Information letter with 
identified patterns and 
themes sent to focus 
group participants to elicit 
whether the 
interpretation was 
congruent.  
24 Self-
management 
behaviors for 
patients with 
chronic 
obstructive 
pulmonary 
disease: a 
qualitative 
study 
 
(Chen, KH., et al. 
2008) 
To explore the self-
management behaviors of 
patients with COPD to 
understand how COPD 
patients manage their 
disease 
No intervention -Convenience sampling. 
Sample size was 
determined by theme 
saturation (data collect 
continued until theme 
saturation was achieved 
during the last two 
interviews) with 
prolonged engagement of 
resourceful participants.  
-Semi-structured, face-to-
face interviews, tape-
recorded, transcribed and 
reviewed.  
-Concurrent data 
collection and data 
analysis. Data analyzed 
using three-step method: 
Participants 
demonstrated the ability 
to choose disease 
management behaviors 
to prevent symptoms 
and complications. 
Identified 5 themes of 
disease management 
behaviors.  
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data reduction (e.g. 
coding), data display (e.g. 
sorting of codes)  and 
conclusion drawing 
(identifying and defining 
themes).  
-Researcher triangulation 
during analysis steps (e.g. 
transcript review, 
interpretation of findings).  
25 The Self-
Management 
Experience of 
People with 
Mild to 
Moderate 
Chronic Kidney 
Disease 
 
(Constantini, L. 
et al. 2008) 
To explore, describe and 
stimulate interest in the 
self-management 
experiences of patients 
with mild to moderate CKD 
No intervention -Purposive sampling to 
ensure representation of 
men and women of 
varying ages. 
-Face to face semi-
structured interviews to 
elicit participant’s 
perceptions on pre-
determined topics. 
Interviews are taped and 
transcribed verbatim. 
Memos were used to 
document non-verbal 
observations. 
-Content analysis 
consisting of line-by-line 
coding of text, repeated 
reviewing of transcripts to 
develop emerging themes. 
-Researcher triangulation 
to confirm findings and 
refine themes. Data 
analysis continued until 
-A number of themes 
were identified.  
-Participants with early 
CKD want to self-
manage their illness in 
collaboration with HCPs.  
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themes seen as accurately 
reflected experiences.  
26 Factors 
contributing to 
intervention 
fidelity in a 
multi-site 
chronic disease 
self-
management 
program 
 
(Perrin, KM., et 
al. 2006) 
To assess the fidelity of a 
CDSM program 
implementation 
The Diabetes Mellitus and 
Hypertension Disease Self-
Management Program based 
on health literacy principles in 
14 community Health Centers 
in Florida 
-Review of documentation 
obtained from 
implementation of a 
larger study: Logs of 
technical assistance and 
field notes, class 
observations, patient 
narratives, exit interviews 
with health educators 
-Qualitative data entered 
into qualitative analysis 
software, reviewed by 
project staff, who 
developed a coding 
scheme and agreed upon 
common themes.  
The program was 
implemented with high 
fidelity to the original 
design.  
27 Qualitative 
evaluation of 
Chronic Disease 
Self-
Management 
Program in 
Shanghai 
 
(Dongbo, F., et 
al. 2006) 
To explore the impact of 
Chronic Disease Self-
management Program on 
participants’ perception of 
their behavior, health 
status and quality of life.  
The Shanghai CDSMP is based 
on the original Stanford 
CDSMP with modifications to 
become more culturally 
acceptable to Chinese 
population 
-Purposeful sampling to 
ensure a broad 
demographic and chronic 
disease spectrum. 
Sampling stopped when 
new topics no longer 
emerged from the last 
three interviews. 
-Semi-structured one-on-
one interviews with an 
interview guide. Audio-
taped and transcribed.  
Content analysis with 
researcher triangulation 
through individual coding 
6 themes emerged.  
The CDSMP was 
perceived to be effective 
to participants, though it 
has a few deficiencies on 
content and delivery 
that need to be 
modified. 
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of transcript, identifying 
and categorizing themes 
which then subsequently 
discussed and refined as 
team.  
-Final interpretation was 
sent to participants for 
validation. 
28 A qualitative 
study of GPs’ 
attitudes to 
self-
management of 
chronic disease 
 
(Blakeman, T. et 
al. 2006) 
To explore General 
Practitioner’s perspectives 
on their involvement in the 
facilitation of CDSM 
No intervention -Purposive sampling to 
acquire a wide range of 
characteristics such as sex, 
practice size and 
contractual status.  
-Semi-structured face-to-
face interviews on pre-
determined areas using an 
interview guide. Audio-
taped and professionally 
transcribed. 
-Open coding. Categories 
are identified by 
comparison of codes. 
Categories found to relate 
to an existing theoretical 
model on the topic 
(Howie’s theoretical 
model).  
Three main themes 
related to three areas of 
the existing theoretical 
model: content of the 
consultation, GP values 
and context in which 
care is provided. 
29 Self-
management 
Training for 
People with 
Chronic 
Disease: A 
To understand 
participant’s experience of 
the CDSMC and 
subsequent use of self-
management techniques 
The Standard Stanford CDSMC 
comprises six, weekly 
sessions, lasting 2 hours each, 
and is delivered by pairs of 
trained lay leaders.  
-Purposeful sampling of 
program participants 
representing a mix of 
diagnoses, age and gender 
using multiple recruitment 
methods.  
-Participants appreciated 
the opportunity to share 
experience in a 
reassuring environment 
by attending the 
program. Goal setting 
50 
 
Shared Learning 
Experience 
 
(Barlow, JH., 
Bancroft, GV., 
Turner, AP. 
2005)  
-Semi-structured phone 
interviews at 4 month and 
12 month post 
intervention on pre-
defined topics. 
Audiotaped and 
transcribed. 
-Content analysis through 
multiple reviewing rounds 
of transcripts, identifying 
emerging themes.  
Researcher triangulation 
through independent data 
analysis and subsequent 
consensus over 
categorization of data. 
was critical in making 
changes.  
30 Volunteer, lay 
tutors’ 
experiences of 
the Chronic 
Disease Self-
management 
Course: being 
valued and 
adding value. 
 
(Barlow, JH., 
Bancroft, GV., 
Turner, AP. 
2005) 
To examine tutor’s 
experience of course 
delivery and their 
perceived impact on their 
own use of self-
management techniques. 
Standard Stanford CDSMC -Purposive sampling to 
give a range of chronic 
disease, age and gender. 
Telephone interviews 
using a guide. Audiotape 
and subsequently 
transcribed. 
-Thematic analysis 
including coding, multiple 
reviews of transcripts and 
identifying and refining 
themes.  
-Researcher triangulation 
by independent data 
analysis by two 
researchers and 
subsequently reaching 
-Being a lay tutor was 
perceived to be 
enjoyable and valuable 
experience despite a 
number of challenges 
associated with course 
delivery.   
-Course delivery 
prompted the initiation 
and maintenance o 
tutors’ own self-
management behaviors.  
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consensus over 
categorization of data.  
31 Qualitative 
Exploration of 
Rural Focus 
Group 
Members’ 
Participation in 
the Chronic 
Disease Self-
Management 
Program, USA 
 
(Harvey, IS, 
Janke, M. 2014) 
To explore the benefits 
perceived by rural 
residents due to their 
participation in the CDSMP 
The Standard Stanford CDSMP -Qualitative exploratory 
study with 
phenomenological 
approach. 
-Six focus groups (34 
participants total). Audio-
taped, transcribed 
verbatim by a research 
assistant and verified by 
another.  
-Thematic analysis 
involving data 
familiarization, coding, 
categorization, developing 
and refining themes. 
Inter-rater using external 
auditor for validation of 
raw data and final themes. 
(Researcher triangulation) 
2 prominent themes 
suggesting that CDSMPs 
can initiate positive 
changes which can in 
turn influence the health 
of rural populations.  
32 Building the 
Evidence Base 
for Chronic 
Disease Self-
management 
Support 
Interventions 
Across Canada 
 
(Johnston, S., et 
al. 2012) 
To determine how to 
improve evaluation of self-
management support in 
Canada 
No intervention -Multi-method approach: 
 Literature Review 
 Internet Scan 
 Stakeholder semi-
structured Interviews 
and subsequent 
thematic analysis 
 Theoretical framework 
review 
 Expert review meeting 
-Four common themes 
identified. -Stakeholders 
need better evidence on 
how to support self-
management in their 
communities. -Outcome 
evaluation must be an 
explicit part of program 
implementation.  
33 A 12-month To describe participants’ Adopted versions of the As part of a larger study, CDSMP participants 
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follow-up study 
of self-
management 
training for 
people with 
chronic disease: 
Are changes 
maintained 
over time? 
 
(Barlow, JH. et 
al. 2005) 
use of self-management 
techniques 12 months 
after commencing the 
CDSMP course 
Stanford CDSMP in the U.K phone interviews were 
conducted with a subset 
of participant, followed by 
content analysis to 
identify themes. 
compared themselves 
with others and were 
motivated to change the 
way they manage their 
conditions. 
34 Chronic disease 
self-
management 
and health 
literacy in four 
ethnic groups 
 
(Shaw, SJ., et al. 
2012) 
To gain insight into day-to-
day chronic disease self-
management practices.  
No intervention 
  
-Participants recruited 
from a community health 
center in a medically 
underserved, refugee 
resettlement area. 
-Combination of focus 
groups and in-depth 
interviews conducted, 
audio-taped, transcribed 
and translated to English 
together with chronic 
disease diaries and home 
visits. 
-Individual coding of 
transcripts, theme 
development and refining 
by three individual coders 
during regular meeting.  
Culturally variable health 
beliefs identified among 
participants interviewed 
that may play important 
roles in their chronic 
disease self-
management practices.  
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5.3. Results 
5.3.1. Usability Studies 
The majority of known innovative products and tools that assist with chronic disease self-management 
have been computer-based applications designed to deliver self-management education2,3,6-8, enhance 
self-efficacy6 or assist with tracking and monitoring of chronic conditions1-2. Reviewed usability studies 
uses two common approaches to evaluation of innovative products or tools: 
Those conducted prior to completion of final prototype1,4,5,7often utilized the user-centered approach by 
asking participants to perform a number of pre-determined tasks, either in their natural setting (e.g. 
home) or within a “testing environment” with the primary goal of refining the developing prototype. 
Collected data has commonly included participant’s perceived usefulness, perceived ease of use, 
satisfaction and areas of improvement using both quantitative and qualitative methods such as post-test 
questionnaires and interviews. Performance measures such as task completion time, frequency of error, 
frequency of help together with non-verbal reactions were also often collected during the testing 
period. 
Other usability studies were conducted at later stages of the product development cycle (e.g. after a 
final functional prototype has been developed) and sought to evaluate clinical effectiveness of the newly 
developed product on outcomes of interest.2,3,6,8 These studies often administered validated clinical 
scales at baseline and periodically to participants during the testing period to measure clinical outcomes 
such as quality of life2,6, self-efficacy6 and satisfaction8. 
 
5.3.2. Qualitative Studies   
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The majority of reviewed qualitative studies on chronic disease self-management have focused on 
evaluating aspects of an existing CDSMP from the participant’s perspective, most notably participant’s 
experience as the result of participating in CDSMP 10,12,15,19,21,27,29 or their motivation for program 
participation 13,16. Other studies have explored program experience and impacts on other stakeholders 
such as spouses 14, professionals 11,18,28 and program leaders 9,22,30. Common qualitative approaches to 
address the research questions have included semi-structured one-on-one interviews 11-18, 20-22, 24-25, 27, 28-
30,34 and focus groups 10,19,23,31,34 as data collection methods; data analysis typically involved 
familiarization with interview transcripts, coding, searching for themes, revising and defining themes 11-
13, 15-18, 20, 22-25, 27, 29-31 in consistent with steps to conduct thematic analysis proposed by Braun and Clarke 
(2006).94 Use of qualitative data analysis software (such as NVivo7) is also common to assist with the 
coding and subsequent analysis steps. Strategies to ensure rigors are also commonly employed and have 
included researcher triangulation (e.g. by having each researcher perform data analysis independently 
and results are reviewed as team) 12,13,15,17,22,24,25,27,29-31,34, data saturation determination (e.g. analysis is 
performed during data collection process to allow for comments on areas requiring additional 
investigation or clarification and to determine when no new data is generated)11,13,24,27, purposive 
sampling (in order to maximize baseline variations) 11,13,16,18,21,23,25,27-30, and participant validation (the 
collected data is “played back” to the informant to check for perceived accuracy and 
reactions)14,17,18,23,27. 
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VI. MEDICATION ADHERENCE 
6.1. Definition and Prevalence 
Medication adherence is an important aspect of chronic disease and medication self-management and 
has been defined as “the extent to which patients take their medications as directed by healthcare 
providers over the prescribed period”.59 
The threshold by which medication adherence is determined is debatable and depends on the condition 
for which the medication is being taken.60 For example; therapies for conditions such as HIV or oral 
contraception generally require a very high level of adherence in order to maintain effectiveness. For 
common chronic conditions such as hypertension, diabetes and hyperlipidemia, patients are usually 
considered adherent if they take more than 80% of the prescribed medications.60 Despite being used in 
many medication adherence studies for categorical purposes, this cut-off point is somewhat arbitrary 
and there is evidence suggesting that there may be additional clinical benefits when going beyond the 
80% cut-off point.61 
Clinical trials have reported adherence rates varying between 43-78% among patients receiving 
treatments for chronic conditions.59 Types of chronic conditions62,63 and duration of treatment therapy64 
also appeared to have an influence on medication adherence. 
 
6.2. Impacts of Medication Adherence on Outcomes and Costs 
Many observational studies have associated better medication adherence with improved outcomes and 
decreased costs of care.65,66,67 However, Ho et al. noted the observed association between adherence 
and outcomes might be in part due to medication adherence being a surrogate marker for the overall 
healthier behaviors such as eating healthy and regular exercising which were the real underlying reasons 
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for improved outcomes.68 This is supported by post-hoc analyses of randomized controlled trials in 
which even adherence to placebo was associated with better outcomes. For instance, in the Beta-
Blocker Heart Attack trial, patients who were non-adherent (defined as taking less than 75% of the 
prescribed medication) had an increased risk of death regardless of whether they were on propranolol 
(OR = 3.1) or placebo (OR=2.5).69 Similar findings were reported in the Canadian Amiodarone Myocardial 
Infarction Arrhythmia Trial (CAMIAT) (increased RR of 2.11 and 3.15 for sudden cardiac death in non-
adherent placebo and treatment groups respectively compared to adherent groups)70  and the 
Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program 
(reduced HR of 0.64 and 0.65 in mortality for adherent placebo and treatment groups respectively).71 
These results suggested that good adherence behavior can be independently associated with improved 
clinical outcome and while not meant to undermine the importance of appropriate medication therapy 
in disease management, they prompted the broadening of adherence definition to include not only 
compliance to medication regimens but also patient ability to carry out other healthy behaviors that 
may affect clinical outcomes.69 
Estimated costs of mediation non-adherence in the U.S range from $100 to $300 billion depending on 
reporting sources.59,66,72 Additionally, between 33 to 69 percent of all medication-related hospital 
admissions in the U.S are reportedly due to poor medication adherence.71 
 
6.3. Causes 
The causes of medication non-adherence are usually multi-factorial. Patient-associated factors include 
depression, physical limitations, cognitive impairments, younger age and lower health literacy. Medical 
conditions that are asymptomatic such as osteoporosis or hyperlipidemia have also been associated 
with higher non-adherence rates.68  
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External factors can also impact medication taking behaviors. For example, institutional processes such 
as medication reconciliation and discharge counseling could play a role in improving patient’s 
understanding of their medication regimen and promote adherence.73,74 Additionally, effective patient-
physician communication could also be important to adherence maintenance.75,76 
The medication regimen itself can also affect adherence. Complex regimens with multiple medications, 
complicated directions of use, high dosing frequency and high costs have all been associated with lower 
adherence levels.77,78,79 
 
6.4. Medication Adherence Measurement Strategies 
Osterberg categorizes methods to measure adherence as either direct or indirect.59 Direct methods 
include observing patients taking medications and measuring serum levels of drugs, metabolites or 
biologic markers. Observing patient taking medications is probably among the most accurate and 
objective methods but is time consuming and often is impractical in clinical settings.68 Measuring serum 
levels is also time consuming, requires expensive equipments and the results can sometime be distorted 
by patients who intentionally take their medications more frequently during the period just before 
testing, a phenomenon known as “white coat adherence”.68  
Indirect methods have included patient self-report, assessing clinical response, performing pill counts, 
reviewing medication refill rates and electronic monitoring devices. 
Obtaining adherence self-report by ways of interviews or validated clinical scales such as the MORISKY 
Scale (Appendix 7) is relatively simple to perform, but is susceptible to patient’s recall bias as well as 
intentional lying which can lead to either under- or over-estimation of actual adherence.68  Assessing 
clinical responses such as blood pressure, blood sugar levels or INR to determine medication adherence 
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can also be confounded by factors other than adherence itself such as diet, disease progression and 
drug interactions.59 
Pill count is one of the most commonly used adherence measurement strategies in clinical trials.68 In this 
method, the actual number of pills in the drug container is counted and compared with the number of 
pills that is supposed to be in the container if the patient was taking the medication as directed. While 
the simplicity and objective nature of this method can be attractive to investigators, it cannot confirm 
whether the missing pills were actually taken by the patient, nor does it reveal the timing of doses taken 
which is important for some medications to be effective. 
Refill records in computerized pharmacy systems have been increasingly utilized as a source for 
adherence information.61 While less time-consuming than pill count, refill record shares the same 
limitations mentioned previously. Nevertheless, a review conducted by Steiner, et al.(1997) found 
significant associations between refill records and other compliance measures and serum drug levels.80 
Moreover; adherence data obtained from refill records has been correlated with a broad range of 
clinical outcomes.81 
Medication Event Monitoring Devices (MEMDs) have been used in clinical trials over the past 30 years to 
obtain adherence data.59 These devices are capable of recording the time the medication bottle was 
opened and thus can provide a more detailed picture on patient’s medication taking behavior such as 
exact date and time the medication was supposedly taken in addition to the overall adherence rate. 
Nevertheless, they still measure medication adherence indirectly and therefore incapable of confirming 
whether the patient actually takes the pill every time the container is opened. Additionally, the high 
costs of these devices prevent them from being widely used outside of clinical trials.59 
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6.5. Overview of Adherence Interventions 
Interventions to improve adherence have been classified into four general categories: patient education, 
improved dosing schedules, improved clinic availability and improved patients-physician 
communication.59  Patient education can be delivered face-to-face , by mail or by phone to patients or 
caregivers and generally aimed at improving disease and medication knowledge as well as self-efficacy.82 
Strategies to improve dosing schedules include use of pill boxes, blister packs, simplifying dosing 
regimen and refill synchronization. Improved clinic availability usually involved making follow-up visits 
more convenient for patients and reducing wait time.59 Finally, improved patient-provider 
communication has included regular telephone follow-ups and mailed communications.82 
Not all interventions have been shown to effectively improve medication adherence.82,83 In fact, even 
the most successful interventions have only led to moderate increases in adherence and treatment 
outcomes.82 Additionally, effective interventions were often complex and included a combination of 
many different strategies which makes generalization problematic, especially on which strategy worked 
and which one did not.82 
 
VII. HEALTH CHALLENGES IN RURAL CANADA 
As we expected the majority of project participants will have come from small towns and rural areas of 
Canada, it was necessary for me to obtain a background on unique challenges rural residents face that 
could prevent them from obtaining needed care. This section highlights some main health challenges of 
Rural Communities and their residents. 
A major challenge to rural Canadians has been accessibility to health services.84 People in rural, remote 
and northern communities often have to travel long distances to obtain medical services. Rural residents 
are on average about 10 kilometers away from a physician compared to less than 2 kilometers for 
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residents in larger urban areas.85 In northern and remote regions of Canada, nearly two-thirds of the 
population lives more than 100 kilometers away from the nearest doctor.86 Geographic isolation, 
coupled with poor road condition, not only compromise access to health services but also directly 
contribute to higher incidence of on-the-road injury.84 
Compared to their urban counterparts, it is harder for rural residents to obtain quality care due to the 
inherent shortage of healthcare providers and services in rural areas. Physicians, especially medical 
specialists and nurses are concentrated in urban locations. Additionally, in many small rural 
communities there are no hospitals, and while the larger rural centers may have hospitals with basic 
facilities, patients typically have to be transported to larger urban centers for specialized treatment.87 
Aside from access to care, the inherent social-cultural structure, economic difficulties and working 
condition also contributes to health vulnerability of residents in rural communities. Most rural 
communities have a high “dependency ratio”, that is, large populations of children and seniors and 
relatively small populations of people of working age. This age distribution is a result of a combination of 
the aging rural population, the tendency of retirees to move into rural areas, and the migration of rural 
youth to urban centers for further education and employment opportunities.85 Rural residents also have 
personal incomes well below the national average, lower levels of formal education and fewer 
employment opportunities compared to their urban counterparts.85 Moreover, rural working conditions 
can pose serious health and safety hazards to rural workers due to the growing use of complex 
machinery, exposure to chemicals, noise, long working hours and extreme temperatures.85 The rates of 
smoking, obesity and physical inactivity in most rural communities have also been reported above the 
national averages84,85 and they are major risk factors for chronic conditions such as diabetes, arthritis 
and high blood pressure and can lead to disabilities. 
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SECTION 2: EVALUATING THE USABILITY OF A MEDICATION 
ORGANIZING TOOL ON MEDICATION SELF-MANAGEMENT AT HOME: A 
PROOF-OF-CONCEPT EXPERIMENT 
 
This section describes our methodological approaches to examine the perceived usefulness of a 
medication organizing tool (the MedManager) to one’s medication self-management tasks, and reports 
on our findings and conclusions.  
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I. OVERVIEW ON THE MEDMANAGER CONCEPTUAL DESIGN, NEED 
ANALYSIS AND PROTOTYPE DEVELOPMENT 
1.1. Conceptual Design 
The “MedManager” design (Appendix 1) was developed by an emergency physician due to his 
experience that many patients arrived at the emergency room without their medications and medical 
information while others had an unorganized way to carry medications with them. This consequently 
reduced staff efficiency and quality of care. The designer believed a tool allows patients to organize 
home medications and medical information that could also be conveniently carried to emergency rooms 
or office visits would be helpful to both patients and health professionals. 
 
1.2. Pre-production Need Analysis 
In order to examine public opinion on this conceptual design, the designer conducted two surveys, one 
with potential end-users, the other with practicing community pharmacists. 
i. End-user Survey (n=10) (Appendix 2) 
Ten potential end-users (unknown baseline characteristics) were shown the MedManager design and 
asked about their medication management habits. Responses from the survey showed that: a) The 
majority of surveyed patients (6 out of 10) reported not having an organized system to manage home 
medications and b) Most (7 out of 10)  were also interested in, and would purchase a product as 
designed if the price was less than $30. 
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ii. Community Pharmacists Survey (n=5) (Appendix 3) 
Five community pharmacists were asked if their pharmacies were selling any systems to assist with 
medication organization and their thoughts on the design. Pillboxes and compliance packaging were the 
only organization tools reportedly available in pharmacies. Additionally, all five pharmacists thought the 
toolkit would be useful for people with multiple medications and is something they would promote to 
their patients. Cost and the large size of the design were mentioned as potential barriers to its use. 
 
In summary, data from the two simple surveys together with the designer’s personal experience as a 
physician suggested that there may be a) Unmet needs in the area of home medication management (as 
reported by surveyed patients and current lacking of a product designed to help with medication 
organization) and b) Interests from both patients and healthcare professionals in the MedManager 
design. 
 
1.3. Prototype Development 
The design had undergone several modifications during prototype development. The final prototype 
which was mass-produced has the following features and components: (Appendix 4) 
 -Storage space for medication vials and medical documents 
-A 7-day pillbox 
-A Medication List Template (Appendix 5) 
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 -A Calendar that also serves as appointment reminder and allows for daily recording of Blood 
Pressure, Blood Sugar and Weight 
 -A Pill Cutter / Magnifying Glass / USB Drive / Notepad 
 
II. PROJECT RATIONALES AND OBJECTIVES 
Ability to manage home medications is important to maintain safety and effectiveness of medication 
regimen and is a significant component of chronic disease self-management process. Efforts to improve 
medication and disease self-management have traditionally been focusing on enhancing self-efficacy 
through education on disease knowledge, problem-solving skills and decision making skills. While this 
approach has improved certain outcomes in the short-term, the effects were often seen to have 
diminished over time after the intervention has stopped. Moreover, the complexity of existing 
interventions coupled with unclear cost-effectiveness can be barriers to their widespread 
implementation outside of clinical trials. These shortcomings justify development and evaluation of 
innovative approaches to further assist patients with self-management tasks. 
We were presented with evidence that many patients may not have an organized way to store their 
medications and medical information at home, and that patients and healthcare providers were 
interested in a design (the MedManager design) intended to assist with home medication organization. 
The usefulness of such tool in the real world however is unknown because to our knowledge, there were 
no similar products available publicly. We therefore would like to see if patients would find the 
MedManager helpful and if they would utilize it in performing medication self-management tasks as 
well as their rationales for utilizing (or not utilizing) the tool.  
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We realized that efforts to understand the rationales for utilizing (or not utilizing) the MedManager 
needs to be based on an understanding of patient’s existing medication management strategies. To our 
knowledge, this area was not well-characterized in existing literature.88,89 We therefore also would like 
to learn how people are currently managing their medications at home including rationales for adopting 
such management strategies and any barriers they currently have. 
Project Objectives: 
a. Primary objective: 
 To determine if introducing the MedManager to participants would lead to its utilization. 
b. Secondary objectives: 
i. To examine the underlying reasons for utilizing (or not utilizing) the MedManager by 
participants. 
ii. To evaluate the effect (if any) of the MedManager on the following clinical outcomes: 
Blood Pressure, Blood Sugar and Weight. 
 
III. METHODOLOGICAL APPROACHES 
3.1. Study Design 
In order to answer the main research question (whether participants would find the MedManager 
useful), we planned to conduct a proof-of-concept experiment where eligible participants would be 
introduced to the MedManager which is made available free-of-charge. An in-person follow-up session 
would then be conducted at participant’s house during which observations are made in each of four 
areas: Medication list, Medication Storage, Adherence Aids, and Clinical Parameter/Symptom Tracking 
in order to understand participant’s existing medication management strategy and to determine 
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whether the MedManager was utilized in each of these areas. This approach reflected the post-positivist 
form of enquiry where the researcher attempts to make a knowledge claim using quantitative strategies 
and methods while ensuring the validity of research claims by remaining objective throughout the 
research process.90 
Our observations would then be followed by a one-on-one semi-structured interview to explore 
participant’s rationales for utilizing existing management strategies and the MedManager if applicable, 
and to obtain any suggestions participants may have for product improvements.  
 
3.2. Inclusion and Exclusion Criteria 
Participants were invited to enroll in the project if they either: 
a) Have expressed interests in using the MedManager toolkit 
-Or- 
b) Have met one of the following criteria:  
 -Take 5 or more chronic medications 
     -Take 12 or more doses per day 
  -Have 3 or more chronic conditions 
   -Have difficulty with remembering to take medications (e.g. medication non-adherence) 
   -Take one of the following medications (Warfarin, Anti-seizures medications, Mood 
stabilizers, Digoxin) 
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   -Have vision problem, dexterity problem (arthritis, etc.), mild cognitive impairment or 
language difficulties 
We were interested in recruiting patients who we believed would be most likely to find the toolkit 
useful. And while it was unclear to us during project planning who, if any at all, would find the 
MedManager useful, since the MedManager was intended primarily as an organizing and adherence-
assisting tool, we thought those who having difficulties with medication organization and adherence 
may find the tool beneficial. Among these are those with complex medication regimens, multiple 
chronic conditions, non-adherent, or have certain conditions that could interfere with performing 
medication management tasks such as vision problems or dexterity problems. Furthermore, we didn’t 
want to limit our recruitment to a rigid set of criteria and therefore also enrolled those who had 
expressed an interest in using the MedManager even though they may not have met our other inclusion 
criteria. 
There were no explicit exclusion criteria. 
 
3.3. Recruitment 
We set recruitment goal at 25 participants based on the number of MedManager we had and 
estimations on other resources made available for the project. Recruitment was done primarily in 
Seaforth, Ontario. We approached potential participants in two main ways: we either invited patients at 
a local pharmacy clinic to complete a screening survey (Appendix 6) following their regular clinic 
appointments or introduced them to the MedManager in-person by way of an information desk set up 
at the Huron Community Care Access Center lobby. Those who met at least one of our inclusion criteria 
were further contacted for enrollment. A number of other recruitment strategies such as newspaper 
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and online advertisements were also tried over the course of the project. Table 6 in the Results section 
listed recruitment strategies attempted and the number of participants we recruited from each strategy. 
 
3.4. The Orientation and Follow-up Sessions 
All enrolled participants received a one-on-one Orientation session where they were introduced to 
project objectives, provided an overview of the MedManager components, and information about the 
follow-up session regarding setting, duration, planned activities and expectations. The MedManager was 
typically delivered to participants at the end of the Orientation session.  
During orientation, we administered the Morisky Scale to enrolled participants in order to assess their 
self-reported medication adherence level. The Morisky Scale (Appendix 7) is a validated four-item scale 
that has been used to assess adherence in many studies including chronic disease self-management 
studies.91,92  The scale classifies patients as having high, intermediate or low adherence based on their 
responses to the four Yes/No questions. Also during the Orientation, we asked participants a series of 
eight Yes/No questions (Appendix 6). These questions were adapted from the Medication Use and Self-
Efficacy (MUSE) Scale which is a brief 8-item scale that has been shown to be reliable to assess self-
efficacy in understanding and using prescription medications.93 
A one-on-one follow-up session was then scheduled to occur within a month of the MedManager 
delivery and was conducted at participant’s home or at an alternate location (e.g. pharmacy clinic) if 
preferred by participants. 11 out of 12 follow-ups were conducted in participant homes. 
During the follow-up session, we examined four areas within the participant medication self-
management process: Medication List, Medication Storage, Adherence Aids and Clinical Tracking 
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System. In each area, using a guide, the study staff recorded a description on existing management 
strategy and whether there were any changes after the MedManager was introduced. 
Also during the follow-up session, using a semi-structured interview format, (Appendix 8) the study staff 
interviewed the participant on his/her perceived advantages and disadvantages of existing management 
strategy and of the MedManager in each of the four areas, together with any suggestions for product 
improvement.  
Table 6 summarizes the two main steps that make up the project intervention 
Table 6:  Two main steps in implementation of project intervention 
Step 1: Orientation 
Recruited participants are introduced to MedManager and study objectives. 
 
Step 2: Follow-up session (preferably at participant’s house) 
● Observations on existing medication management strategies and 
MedManager utilization in each of four pre-determined areas 
● Interviews on perceived advantages and disadvantages of existing 
medication management strategies, benefits of the MedManager and 
suggestions for product improvement 
 
3.5. Data Collection and Analysis 
We collected data on a) Participants’ Baseline Characteristics (Table 8), b) Descriptions on existing 
medication management strategies (Tables 9 and 11), c) Utilization of MedManager components (Table 
10) and d) Suggestions for improvement (Table 12). Data was collected primarily from the screening 
surveys and during follow-up sessions.  
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In an attempt to quantify participant’s overall utilization of the MedManager, we assigned points to 
each component based on their utilization status at follow-up as followed:  
-Currently Using: 2 points  
-Not Using/Plan to Use: 1 point  
-Not using/Do not plan to use: 0 point  
We then calculated the total points earned by each participant to come up with their overall 
MedManager “Utilization scores” and plotted the scores against selected baseline characteristics to 
determine if there would be a correlation. We also examined for correlation between utilization of the 
MedManager’s storage function exclusively against selected baseline characteristics as this is the most 
important function of the tool. 
In order to analyze qualitative data collected during observations and interviews, we performed 
thematic analysis on notes obtained from follow-up sessions. Written notes were digitized, typically on 
the day obtained, in order to improve clarity and give the investigator a chance to review for accuracy 
and completeness as well as to become more familiar with collected data. We then identified codes 
from the processed data and sorted them under pre-defined categories together with associated 
observations, participant responses or quotes from which the codes were generated. Codes identified 
within each category were then examined to identify common themes. These themes were then 
reported together with associated quotes and observations as illustrations. Our thematic analysis steps 
were similar to those proposed by Braun and Clarke (2006), which consisted of data familiarization, 
generating initial codes, looking for themes, revising developed themes and defining themes.94,95 
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IV. RESULTS 
4.1. Recruitment and Retention 
Figure 2 summarizes our recruitment process and retention 
 
Figure 2: Overview of Project Recruitment and Retention at Follow-up  
 
21 Eligible Participants contacted 
for enrollment 
 
 
 
 
 
 
3 lost to follow-up (no respond to 
subsequent contacts) 
 
 
12 completed Follow-up session 
 
 
 
 
 
15 Eligible Participants Enrolled 
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Table 7: Attempted recruitment strategies and number of participants recruited from each strategy 
 
Recruitment Source  Number recruited Number completed follow-up interview 
Pharmacy clinic at local FHT 9 8 
Information table at FHT lobby 3 3 
Local research organization 2 0 
Referrals from local physicians 1 1 
Advertisement on local newspaper 
and hospital website 
0 0 
Direct emailing to potential 
participants 
0 0 
Total 15 12 
 
We found direct, face-to-face recruitment strategies were more effective than indirect strategies (e.g. 
advertisement or emailing). Furthermore, an established trusting relationship with participants and 
physicians played an important role in recruitment successes as we observed hesitancy from both 
potential patients and physicians due to perceived project commitments and the unknown variables 
associated with the MedManager use. 
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4.2. Baseline Characteristics 
Key baseline characteristics of participants are summarized in Table 8 below. Our sample consisted 
mostly of participants 50 years of age or older and had a somewhat balanced gender mix. Many had 
relatively complex medication regimens with 9 out of 12 participants take seven or more regular 
medications up to 5 times daily. Most participants also demonstrated high levels of medication 
adherence as evidenced by the MORISKY Scores and self-reported number of times forgets to take 
medications per week (mean = 0.7/week).  Additionally, most participants also reported a strong belief 
in their ability to learn about and use medications per their responses to screening survey questions. 
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Table 8: Participant’s Baseline Characteristics (n=12) 
 Mean (Range, SD) 
Age 60-69* (<40 - >69, n/a) 
Gender 7F/5M  
Regular medications 7.8 (2 - 13, 3.22) 
Times to take scheduled 
medications per day 
2.7 (1 - 5, 1.07) 
Times forget to take medications 
per week 
0.7 (0 - 2, 0.78) 
Number of pharmacy(s) 1.2 (1 - 3, 0.58) 
Primary physician visits over last 12 
months 
4.6 (1 - 14, 3.86) 
MORISKY Score (0-4) 3.6 (3 - 4, 0.52) 
Time to follow-up (days) 26.8 (18-33, 3.93) 
*Most commonly reported age group 
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4.3. Summary of Existing Medication Self-Management Strategies and Utilization of 
MedManager at Follow-up 
 
Tables 9 and 10 summarize our observations on characteristics of participant’s existing medication self-
management strategies and utilization of the MedManager at follow-up in the four pre-determined 
areas.  
Table 9: Characterizations of Participant’s Existing Medication Self-management Strategies (n=12) 
 YES NO 
Medication list 
● Self-made 
○ Hand-written 
○ Electronic 
● Prepared 
○ By Hospital 
○ By Pharmacy 
○ Spouse/Relative 
8 
4 
2 
2 
4 
1 
2 
1 
4 
Medication storage location 
● Kitchen 
● Livingroom 
● Bedroom 
● Bathroom 
● Other 
12 
5 
3 
2 
2 
0 
0 
Medication storage container 
● Cabinet 
12 
6 
0 
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● Plastic container 
● Open surface/Not reported 
4 
2 
Medication Adherence Aids 
● Pillbox 
● Blisterpacks 
7 
6 
1 
5 
Clinical parameter or symptom tracking 
system at home 
● Notebooks 
● Blood glucose meter 
3 
2 
1 
9 
 
*Section 4.5 provides a more detailed discussion on existing medication self-management strategies. 
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Table 10: Utilization of MedManager Components at Follow-up (n=12) 
 
Component Using Not Using/Plan to use Not Using/Do not plan 
to use 
Medication List 
Template 
0 6 6 
Storage function 7 0 5 
Provided Pillbox 4 3 5 
Calendar 2 1 9 
Pill cutter, Magnifying 
glass or USB drive 
1 1 10 
 
Our participants also had a mean Utility Score of 3.1 (Range=0-7, SD=2.43). (The Methods section 
explains the purpose of Utility Scores and how they are calculated.) 
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4.4. Correlation between MedManager Utilization and selected Baseline Characteristics 
 
We were interested in examining if certain baseline characteristics could have an influence on 
MedManager utilization. The following Charts present sub-group comparisons on the MedManager 
utilization in selected baseline characteristics using the calculated Utilization Scores (Charts 1-3). 
Additionally, we also looked specifically at utilization of the MedManager’s storage function (Charts 4 
and 5).  
 
 
 
Chart 1: Scatter Diagram of Participant’s Utilization Score by Number of Medications 
*Higher Utility Scores represent higher overall utilization 
 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
0 2 4 6 8 10 12 14 
Utilization Score 
# Regular Medications 
Utilization Scores by Number of Regular Medications 
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In general, we do observe a correlation between participants’ number of medications and their 
Utilization Scores with the exception of a few outliners (as shown in red) in Chart 1. Additionally, 
participants using plastic containers as storage system and those had a self-made medication list had 
higher mean Utilization Scores compared to alternatives as shown in Charts 2 and 3 below.  
 
Chart 2: Participant’s Utilization Score by Type of Storage Container 
 
 
Chart 3: Participant’s Utilization Score by Existence and Type of Medication List 
0 
1 
2 
3 
4 
5 
6 
7 
8 
0 1 2 3 4 5 6 7 
Utilization 
 Score 
Participants 
Plastic Container  
(mean = 4.8) 
Cabinet  
(mean =1.8) 
Open surface/Unknown  
(mean=3.5) 
3.75 
2.5 
3 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
YES/Self-Made YES/Prepared NO 
Utilization  
Score 
Existence and Type of Medication List 
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Looking specifically at utilization of the MedManager storage function, those recruited from lobby and 
those previously utilized plastic containers were seen more likely than others to have later utilized the 
MedManager as storage space (at 67% and 100% utilization respectively). This is shown in Charts 4 and 
5. 
 
 
Chart 4: Participant’s Utilization of the MedManager’s Storage Function by Recruitment Source 
*YES: Utilizers - NO: Non-Utilizers 
 
 
 
 
 
Chart 5: Participant’s Utilization of the MedManager’s Storage Function by Existing Storage System 
*YES: Utilizers - NO: Non-Utilizers 
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4.5. A Closer Look at Participant’s Existing Medication Management Strategies and 
MedManager Utilization 
4.5.1. Medication List 
Participants adapted a wide variety of medication lists. Observed lists ranged from simple hand-written 
lists containing only names and dosages of medications to more detailed computer-generated lists 
created by hospitals and pharmacies containing information such as number of repeats, on-hold 
prescriptions and personalized notes written by pharmacists. Allergies and emergency contact 
information were commonly seen missing from observed lists. Hand written medication lists were 
typically small in size and usually allowed for convenient storage in a wallet or purse while those printed 
by hospitals and pharmacy were often on multiple A4 pages and would necessitate use of some sort of 
folder to store and carry around. Electronic medication lists were typically typed into smart phones 
using a note-written application and were relatively simple. 
 
Participants utilized medication lists mainly as tool to effectively inform healthcare providers of current 
medications regimen at time of visits. Mentioned health care providers include family physicians, non-
regular physicians, hospital staff, ER and EMS staff.  
 “The [new] eye doctor asked me for the [medication] list...” 
 “[A medication list] could be handy in case [I have a] medical emergency at home or at the ER.” 
 
Conversely, participants without a medication list commonly cited a lack of need for one, most 
commonly on the ground that physicians already have their medication profiles in computers or that 
they can remember their medication regimen.  
 “It’s one of the things I always wanted to do, but I just don’t feel the need for it… The doctor 
office has my medication list on file.” 
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 ‘I used to write down what I had been taking, but since [the number of] my medications was cut 
down, I didn’t feel the need [for keeping a medication list] anymore.” 
 “My wife knows what I’m taking and she’s usually with me at hospital and doctor office” 
 “I have them in my head.” 
 “I can look at the pill bottles”  
 
The provided medication list template (Appendix 5) was not well utilized by participants. Half of 
participants however indicated at follow-up visit that they would fill it out at a later time. Participants 
reconsidered the template after being informed by the interviewer of its advantages; for instance the 
list allows for recording of information such as allergies and emergency contacts; is easier to carry than 
some existing larger lists and it could be more easily accessible by EMS staff in case of emergency 
compared to those inside smart phones.  
 
4.5.2. Medication Storage Location and Container 
 
Medications were often stored at locations fit into the participant’s daily habit so that it is convenient for 
medication taking and also to serve as adherence reminder.  
 “[I store my medications in the kitchen because] I can take them with water and some food 
which are always available [in the kitchen].” 
“As someone with brain injury, things have to be consistent [to me]. I wake up every morning, go 
to the bathroom, see the pills, take the pills out to go to the kitchen and take it with milk.” 
 “[The kitchen] is the first place I walk to when I wake up.” 
 “[I keep them in the living room because] this is where I live.” 
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Participants mentioned convenient access to medications, be secured, and allow for organization of 
medications as desirable qualities of a storage system. Cabinets and simple plastic containers are the 
two commonly seen storage systems and neither met all of these qualities. Cabinets are commonly 
available in houses especially in kitchens and participants often cited their ability to allow for secured 
storage and easy organization of medications (e.g. on shelves). 
“[I] put them up in the cabinet so they are safe from our grandkids” 
 “[The cabinet] helps keep medications organized.” 
 
On the other hand, those using simple plastic containers often cited reachability and togetherness: 
 “[The plastic container] helps keeping [my medications] together.” 
 “It’s [the plastic container] handy, it keeps everything together and makes you feel secured.” 
 
Participants using plastic containers nevertheless mentioned lack of organizability, risks of missing 
medications and unauthorized access to medications as disadvantages of their storage system: 
 “My medications [in the plastic container] were all over the places.” 
 “It [sometimes] takes me like an hour-and-a-half to find my medication” 
 “Sometimes it’s hard for me to find things [inside the plastic container] … like the Spiriva pills” 
 “I fear of them getting lost. I used to lose my pill bottle and [later] found it under the couch” 
 “I have a cat that comes dig in my medications.” 
 
The MedManager was utilized by a number of participants as new storage system for its improved 
organizability, visibility and security that helped improve participants’ sense of control over the 
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medication regimen. This was frequently expressed by four participants who previously used plastic 
containers to store medications, all of whom subsequently utilized the MedManager.  
 “[The toolkit] makes it so much easier for me to visualize [information on medication bottles] 
[compared to the plastic container] for example, when I need refills.” 
 “I have a cat that comes dig in my medications [in a plastic container].” 
“Before [using the MedManager] my medications were all over the places [due to the open 
nature of the plastic container].” 
“It keeps everything in one place.” 
 
We also observed that some participants kept their pillboxes and emergency medications (e.g. inhalers) 
outside the MedManager at accessible locations while utilizing the tool to store medication vials and 
medical documents. The MedManager could then be put away at a separate location where it is 
accessed only periodically for pillbox refills.  
 
Another perceived advantage of the MedManager as storage system is its portability that allowed for 
convenient carrying of medications outside the house.  A couple of our participants reported to have 
utilized the MedManager as carrying tool during the study period, while others have expressed their 
intention for such use.  
“It’s handy to carry around. Last time [I] went fishing for a week, I took the case with me and I 
had everything I needed.”  
“I had to go to the hospital [last week]… I took the whole case to the hospital [and showed it to 
medical staff]… and they thought it was a great idea.” 
“I have all my home medications [in the case]...When I have to go to the hospital, I can just take 
the case with me and hand them [the case]”.  
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“This will become handy in case of emergency. We have tornado weather here in Seaforth. If 
there is a tornado warning, we can go to the laundry room with the case… and [also] to keep it 
[my medications] dry.” 
 
Those who didn’t utilize the MedManager as a storage and carrying tool, while praises its organizability, 
commonly cited the tool’s large size as barrier. This view was commonly expressed by participants taking 
a relatively small number of medications (less than 5). Additionally, one participant on wheel chair 
thought carrying the case with him while traveling is inconvenient. 
“... It could be half the size.” 
“It’s inconvenient [for me] to carry around [because I’m on a wheelchair].” 
 
4.5.3. Adherence Aids 
Many study participants have already been using pillboxes to help simplify the medication taking 
process. Observed pillboxes come in different designs and served somewhat different purposes. For 
instance, some participants put all regular medications in a multi-compartment-per-day pillbox, others 
put only selected doses (e.g. morning doses) or selected short-term medications (e.g. prednisone) in 
single compartmental pillboxes while keeping other regular medications inside bottles. Commonly cited 
benefits of pillboxes were convenience, adherence reminders and adherence tracking. Specifically, 
utilizing a pillbox can reduce the number of times participants have to open medication vials and make it 
easy to track whether the pills was taken. Additionally, pillboxes can be put at a more visible location 
(e.g. on kitchen table) to serve as adherence reminder.  
 “It’s convenient so I don’t have to open the vials every day.” 
 “I remember to take the Vimovo in the morning with my blood pressure pills, but sometimes 
forget to take it [by itself] at night, [so the pillbox helps with that].” 
 “This way I can tell whether I missed a pill or not.” 
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 “It helps keep things organized.” 
 
Conversely, those without pillboxes cited forgetfulness, impracticability and lack of need for one as 
reasons: 
 “[If I was to use a pillbox], I would need to fill the pillbox up every week, and I might forget [as 
someone with brain injury].” 
 “It doesn’t work for me. All my pills don’t fit in the compartment. … [Plus] I don’t find the time to 
do it.” 
 “I [only] take two medications in the morning” 
 
One participant who is on wheelchair chose blister pack as adherence aid to further simplify the 
medication taking and carrying process: 
 “When we go to London to see our kids, I can cut out the blister packs and carry them in [the] 
backpack.” 
 
4.5.4. Clinical Parameter and Symptoms Tracking Systems 
Most participants had not been keeping track of clinical parameters or symptoms. Three observed 
tracking strategies were automatic storing of blood glucose values by the glucometer; hand-writing daily 
blood pressure and blood sugar numbers inside a small booklet and one participant has been 
documenting her symptoms and possible precipitating factors in a small notebook as they occur. These 
tracking tools were reportedly often brought to physician office to assist with symptom monitoring.  
 “[I write down] when my breathing was hard… or when my sinus is logging”. “I think it really 
helps the doctors monitoring my case.” 
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Those who did not utilize a tracking system often cited lack of (or no longer have) needs for such system: 
 “It [my blood pressure] fluctuates a lot nowadays [so the numbers doesn’t mean much], and I 
have enough common sense to go to the ER when I don’t feel good.” 
 “I check my blood pressure when I’m at the pharmacy, [and] I have blood work done at the 
hospital.” 
“[I] used to weigh [myself] every morning and had a piece of paper in the bathroom to write the 
numbers down but don’t do that anymore... because I’m feeling good.” 
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Table 11: Summary of perceived benefits and barriers of existing medication self-management strategies 
in the four main areas as reported by participants: 
 Perceived benefits Perceived barriers 
Medication list ● Inform new or non-
regular HCPs of 
medication regimen 
● Inform EMS staff in 
cases of emergency or if 
can’t communicate 
verbally. 
● Some are too large to 
carry around 
● Providers can’t access to   
phone in cases of 
emergency 
Medication storage location ● Convenient to daily 
habits 
● Adherence reminder  
● None reported 
Medication container Cabinet 
● Organizability 
● Security 
 
Plastic Container 
● Convenience 
● Togetherness 
● Reachability 
Cabinet 
● Relatively inconvenient 
access 
 
Plastic Container 
● Lack of organizability 
● Unauthorized access 
● Risks of missing 
medications 
Adherence Aids (Pillboxes and 
Blisterpacks) 
● More convenient to  
medication taking vs. 
vials 
● Medication taking 
reminder 
● Adherence tracking 
● Needs to be refilled up 
at least one per week 
● Commercially available 
pillboxes may not meet 
patient specific needs 
(e.g. take medications 
more than 4 times/day 
or large pills don’t all fit 
into compartment) 
● Lack of perceived need 
if simple medication 
regimen 
Clinical parameter and symptom 
tracking system 
● Assist physicians with 
disease monitoring 
● None reported 
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Also during the interviews, we asked participants about their perceived disadvantages of the 
MedManager (if any). Table 12 lists these perceived disadvantages and suggested solutions offered by 
participants. 
 
Table 12: Perceived Barriers of the MedManager as a Medication Organizing Tool and Suggested 
Solutions from Participants 
Perceived Barriers Suggested Solutions 
Unnecessarily large ● Smaller version for people with less 
number of medications (e.g. only one row 
of vial holders) 
Rubber bands are hard to fit medication vials in  
 
Rubber bands could lose their elasticity after 
some time 
● Adjustable rubber bands 
 
● Using vicryl as medication bottle holder 
Dates on Calendar doesn’t print correctly ● Verify dates on calendar 
Pillbox material breaks off after multiple 
open/close 
● Consider more durable material for 
pillboxes 
Pillbox only has two compartments for each day ● Consider three compartments/day pillbox 
design for those taking meds more than 
twice daily 
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V. DISCUSSION AND RECOMMENDATIONS 
5.1. Barriers seen in Existing Medication Management Strategies 
Absence of an effective medication organizing and carrying tool was seen in many project participants 
with multiple medications, who typically used a plastic container or cabinet to store home medications. 
As reported by participants, lack of organization can lead to the feeling of “not in control” of the 
medication regimen and interfere with medication adherence and communication with healthcare 
providers. This observation strengthened our prior assumption that there is a perceived need for better 
organizing and carrying of home medications. Efforts to characterize and address this need nevertheless 
should be done with cautioned and should take into account that what is perceived as difficulty or 
barrier to one might not be similarly perceived by others. Consequently, interventions designed based 
on generalization of perceived needs may not be very effective to the population as a whole. Moreover, 
daily habits often play an important role in determining medication management strategies as seen in 
our participants and in the literature89 and they are often not easily changed. These observations led us 
to believe that efforts to improve home medication self-management should best be individualized, 
starting with examining patient-specific needs and preferences and taking into account patient’s daily 
habits. 
We also observed that the act of maintaining a medication list as well as the nature of the medication 
list (e.g. self-made vs. prepared) often correlated with participant’s understanding of their medications 
and chronic conditions. For example, during interviews, participants with self-made medication lists 
were seen as being more knowledgeable about their medication regimen compared to those without a 
list and on average also reported higher Morisky Scores (4 compared to 3.3). Again, generalization of 
this correlation should be done with caution, taking into account considerations such as the complexity 
of patient’s medication regimen as well as the patient’s perceived needs for such list. As mentioned 
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previously, most observed lists did not include allergies or emergency contact information. Moreover, 
many participants did not keep a medication list (4 out of 12) either due to lack of perceived needs for 
one or the perceived “hassles” of maintaining one, for example, due to frequent medication changes 
and complex regimens. Maintaining a detailed medication list is an important aspect of chronic disease 
self-management20 and can be beneficial to patients and healthcare providers especially in case of 
emergencies. 
Pillboxes were the most commonly seen adherence aid, used by 50% of participants (6 out of 12). For 
reference purposes, a cross-sectional study has reported a pillbox prevalence of 80% in their diabetic 
participants.89 Pillboxes simplify the medication taking process by sparing patients from having to open 
medication vials multiple times a day and can help patients track whether a pill had been taken or not. 
Pillboxes also can be more convenient to carry while away compared to medication vials, especially for 
those with multiple medications. They however typically need to be refilled once per week, which in 
itself can be a time-consuming process and barrier to those with cognitive impairment or functional 
disability. Additionally, pillboxes are not suitable for certain types of medications such as “as-needed” or 
inhaled medications therefore do not help with adherence to these medications. Moreover, patients 
with unusually large number of medications may find it impossible to fit all pills inside a typical 
compartment, while those who take medications more than four times daily may have problems finding 
a pillbox design that fit their medication taking schedule since the majority of available pillboxes have 
four compartments per day or less. 
 
5.2. Perceived Usefulness of the MedManager as a Medication Management System 
While the MedManager contains a number of components, the key value that is also unique to the tool 
was its storage function and portability. More than half of our participants (7 out of 12) utilized the 
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MedManager as a medication storage tool at follow-up; two of whom also had carried the tool with 
them while away or to the hospital while others had expressed intention for such use. We believed the 
observed utilization coupled with perceived advantages of the MedManager over existing storage 
systems as reported by participants demonstrated its feasibility to act as a medication organization and 
carrying tool in the real world. Other components of the MedManager, namely the medication list, 
pillbox and reminding calendar were not innovative in nature, nevertheless their inclusion within a 
single “toolkit” can promote their utilization in patients otherwise may not have been aware of the 
potential benefits of these components. For example, many patients may not be aware of the benefits 
of maintaining a current medication list, especially in cases of medical emergencies where access to 
medical records may not be immediately available. Like all products, however, utilization of the 
MedManager in this project was not universal which made it important to determine which patient 
demographics would be more likely to find the toolkit beneficial and this is discussed in the next section.  
Our project has also revealed some potential disadvantages of the MedManager. First, there were a 
number of suggestions for product improvements offered by participants as mentioned in Table 11. 
Second, while we wasn’t informed of any risks or potential risks associated with the MedManager use, 
the short study period might have been inadequate to uncover unforeseen risks associated with its use. 
For instance, the risks of losing or misplacing the MedManager during transportation together with its 
contents cannot be excluded though one may argue that this risk might be comparable to the 
participant’s traditional methods of medication carrying. Lastly, the durability of the toolkit and 
acceptable price range were not known to us as they were not examined in this project.  
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5.3. Likely Utilizers of the MedManager 
Determining which patient population would be most likely to utilize the tool is of key importance if the 
tool is to be promoted. In our project, all four participants who previously stored their medications in 
plastic containers subsequently utilized the MedManager as new storage system, two of whom also had 
carried the tool with them outside their homes (one while on a fishing trip and the other to hospital). 
Furthermore, these four participants also had relatively complex medication regimens (taking 8 regular 
medications or more). This suggests that those without an effective storage system or those with 
complex medication regimen may be more likely to find the tool useful. Nevertheless, it does not 
necessarily mean that the tool doesn’t have a role in patients with less complex medication regimens. 
While these individuals might not have much difficulty with medication organization and adherence, the 
tool still can serve as a “portable storage cabinet” for home medications and medical files that can be 
kept at a more convenient or secured locations. This could become relevant in patients who also utilize 
weekly pillboxes and only need to access their medication vials periodically for pillbox refills as seen in a 
couple of our participants. 
Participant’s initial level of interest in the MedManager could be another potential predictor for the 
tool’s utilization. While all participants in our project have expressed some level of interests in the tool 
prior to enrollment, those who actively communicated their interests to us were better utilizers. 
Specifically, those recruited from information desks were seen as more likely to utilize the tool 
compared to those recruited through screening surveys at clinic (Chart 4). These observations then 
suggests that “non-invasive” promotion strategies that aimed solely at raising patient’s awareness of the 
tool such as newspaper advertisement or visual display at retail locations may be effective in reaching 
likely utilizers.  
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We couldn’t find any correlation between other baseline characteristics such as Age or Adherence 
Measure (e.g. the Morisky Scale) and the MedManager utilization.  
 
5.4. Project Strengths and Limitations 
5.4.1. Strengths 
Compared to other possible methodological approaches to address the research question, ours had a 
number of advantages.  
With regards to recruitment, the flexibility in our inclusion criteria allowed for examination of the tool 
on a wider range of potential users instead of self-limiting our enrollment to only those with pre-
determined characteristics. The approach was justifiable given the “uniqueness” of the tool during 
project planning which made defining target-user characteristics seemingly speculative. Additionally, we 
tried a variety of recruitment methods which allowed for examination on which recruitment strategy 
worked and which one did not. Specifically, those recruited through “non-invasive” recruitment 
strategies (e.g. information desk) which encouraged participant’s initiation of the conversation had 
better utilization rates compared to those recruited through more “invasive” strategies such as asking 
patients to fill out the screening survey.  
Secondly, we collected descriptive data (e.g. on existing self-management strategies or MedManager 
utilization) mostly through direct observation in participant homes. Compared to other possible data 
collection methods such as surveys or interviews, direct observation reduces risks for reporting biases 
because the participants did not have to describe their management strategies themselves and the 
investigator did not have to interpret their responses. Moreover, during our interviews with 
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participants, direct observation often allowed us to better visualize participant talk points and in many 
cases, helped confirm the validity of their responses.  
Lastly, the explanatory mixed methods approach by which the initial quantitative results are further 
explained with qualitative data90 provided mechanism for deeper understanding of objective 
observations, something that would have been difficult to achieve with either quantitative or qualitative 
methods alone. For instance, the participant interviews helped us understand the rationales behind the 
observed utilization (or non-utilization) of the tool and helped strengthen our conclusion that the 
observed utilization is in fact due to the participant’s perceived usefulness of the tool instead of 
confounding factors.  
It is also worth noting that there are many ways to evaluate a product’s usability.97 Traditional usability 
testing typically involves asking targeted end-users to perform representative tasks (e.g. by providing 
them with a task list) within an artificial testing environment.98 While this approach would have allowed 
us to examine the perceived advantages and disadvantages of each MedManager components more 
closely, it does not allow for observations on actual utilization and subsequently, characterization of 
likely utilizers which were our outcomes of interest. This project instead utilized the “what-if” approach 
often seen in proof-of-concept experiments that supposedly would allow us to examine these outcomes.  
 
5.4.2. Limitations 
We were not able to meet our recruitment target within the pre-defined recruitment period. This could 
be attributed to the inefficiency seen in many of our recruitment strategies. The implication of a 
reduced sample size is that it may have diminished the “richness” of quantitative and qualitative data 
collected. Additionally, the lack of a randomization process, sample size calculation and a well-defined 
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patient population prevented us from making inferences on how representative our observations (e.g. 
on prevalence of an existing self-management strategies) were compared to the actual prevalence in the 
general population or to any sub-population as well as what the actual effect size of our intervention 
(e.g. actual MedManager utilization rate) would be on such population. 
We were also concerned with the possible influence of the observer effect (a.k.a Hawthorne effect) on 
the observed utilization of the MedManager. In order words, participants’ actual utilization in their 
natural, unobserved setting might have been different from what was observed in this project. This is 
because people who know that they are being observed may temporarily change their behavior or 
performance.99 While it was not possible to make our project truly unobtrusive (e.g. making participants 
unaware that they were being studied), we had taken several steps to reduce possible impacts of the 
observer effect during project implementation. Firstly, we maintained a neutral perspective on the 
effectiveness of the tool during our interactions with participants and emphasized that the toolkit is still 
in its prototype form and might not work as intended. Additionally, requests for project participation 
were made in the most non-committal way possible to reduce participant’s “perceived obligations”. 
Furthermore, during orientation we objectively introduced the functions of the MedManager and its 
components using scripted paragraphs without explicitly telling participants how or if they should use 
the tool. These steps were intended to reduce the possibility of participants performing project activities 
in ways perceived by them as beneficial to project objectives. Additionally, two participants informed us 
that they had utilized the MedManager as a carrying tool (one while on fishing trip and other to 
hospital), these were unlikely the results of the observer effect or perceived obligations but probably 
due to the perceived benefits of the tool. Moreover, we observed what we thought was genuine 
interests in the MedManager as an organizing tool from a number of participants during our interviews. 
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In short, we had reasons to believe that the observer effect was unlikely the deciding factor leading to 
the observed utilization of the MedManager. 
Data analysis was performed primarily by the student investigator. The lack of researcher triangulation 
makes interpretations more prone to biases as “involvement of a number of researchers can be seen as 
an advantage as their different perspectives can enrich the research process”.95 
And lastly, we did not report on one of our secondary objectives that attempted to evaluate the effect 
of the MedManager on selected clinical outcomes (Blood Pressure, Blood Sugar and Weight). This is 
because only two of our participants tracked their clinical parameters on a scheduled basis and neither 
was utilizer of the MedManager at follow-up.  
 
5.5. Project Implications and Future Directions 
5.5.1. Considerations for Promotion of the MedManager as a Medication Organizing Tool 
A common approach to new product development is Human Factor Engineering which is “the practice of 
designing products so that users can perform required tasks with a minimum of stress and maximum of 
efficiency.”96 This philosophy places the user at the center of the product development process and that 
the product’s goals, objectives, context and environment are derived from the user’s point of view.97 
Within this context, a key step in promoting the MedManager would be to define its end-users: those 
who would be most likely find the tool beneficial. As mentioned earlier, we observed that those without 
an organized medication storage system and those who expressed interests in the displayed sample 
(e.g. at information desk) were more likely to later become utilizer. This then suggested that 
promotional approaches such as displaying the tool at retail locations including community pharmacies 
can be a good marketing strategy to reach potential users. Additionally, making the tool and its purposes 
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known to health professionals such as pharmacists and family physicians can also be an effective 
promotional strategy as these professionals have the tools to identify likely utilizers (e.g. those with 
complex medication regimens) and can recommend the MedManager where appropriate. 
Given the early stage of this product, feedback from end-users and experts are also important and 
should be taken into considerations for future modifications. Moreover, there are many relevant 
questions that were not answered by this project; among them were the durability of the toolkit, its 
effectiveness on clinical outcomes if any, and possible risks associated with its use.  Continuous quality 
assurance measures (e.g. through establishing and maintaining communication channels with end-users 
and health professionals) can help answer some of these questions, while others may require 
implementations of larger, well-designed clinical trials. 
 
5.5.2. Future Considerations for Sample Size Determination 
In a typical usability test, the number of participants depends on many factors such as the degree of 
confidence in the results that is required, the number of available resource to set up and conduct the 
test and the availability of the type of participants required.97 Additionally, usability tests requiring 
statistically valid results will need to test enough participants to conduct the appropriate analyses and 
generalize to the specific target population, as well as to rigorously control for potentially biasing 
conditions and factors.97 Neilson suggested the number of participants needed for a typical usability test 
is 5 participants, although quantitative studies (aiming at statistics, not insights) requires testing at least 
20 participants, if not more, to get statistically significant numbers.100 Therefore, if the testing goal is to 
try to expose as many usability problems as possible in the shortest amount of time, then testing four to 
five participants should expose the majority of usability problems.97,101 However, Rubin mentioned that 
testing only four to five participants may overlook rare problems that could have severe ramifications 
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and that up to eight participants can be recruited if possible.97 Another important consideration is 
whether more tests will be conducted during the product development cycle. If multiple tests are to be 
conducted, one may feel more confident testing fewer participants. If no other tests were expected to 
be conducted then more participants should be considered.97 Our project differs from a typical usability 
test in that we approached the question as a neutral researcher who would like to observe usability, 
rather than as a designer who tries to enhance usability. Consequently, we decided to limit our sample 
size only on the estimated time and resources made available and the number of eligible participants 
recruited rather than on known recommendations at project planning. Nevertheless, we had seven 
participants who utilized the MedManager’s storage function and therefore had reasons to believe that 
the usability problems suggested by these participants (Table 12) should probably represent the 
majority of usability problems in this particular area. Known usability tests of innovative self-
management tools and products have included varied sample sizes ranging from 8 to 50 subjects 
without clear explanation of the basis for the size selected. 1,4,7 Future studies that focus on exposing 
additional usability problems should utilize current recommendations for sample size determination as 
mentioned above, while those aiming at evaluating effects on clinical outcomes should consider 
performing the appropriate statistical analyses to ensure their sample size has the desired statistical 
power for the research question.  
While not stated as a primary objective, our project included a qualitative component. In qualitative 
research, there is no rigidly set formula to determine sample size.95 For most qualitative projects, the 
sampling process is flexible, and at the start of the research the number of participants to be recruited is 
not definitely known.95 However, data saturation, a concept associated with grounded theory, is often 
used as a way of justifying the number of research participants  and the sample size is considered 
adequate when “the emerging themes have been efficiently and effectively saturated with optimal 
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quality data”.95 A common approach to achieve data saturation seen with qualitative studies in chronic 
disease self-management was to conduct semi-structured interviews or focus groups on purposively 
sampled participants and with concurrent data analysis where the analysis process allowed for 
identification of themes and guided subsequent data collection in order to further refine identified 
themes until few new data is generated.12,14,25,28  As mentioned earlier, our sample size was based 
primarily on logistics factor and data saturation was not a consideration during project planning. 
Furthermore, qualitative categories (e.g. advantages of current medication lists – see Appendix 8) were 
pre-determined during project planning and the large number of categories in this project implies it 
could be possible that not all of them have achieved data saturation at the conclusion of data collection. 
  
5.5.3. Implications for the MedManager within context of the Chronic Disease Self-Management 
Process 
In the research setting, incorporation of innovative tools as part of self-management interventions is not 
new.,102,103 The MedManager’s feasibility to serve as a medication organizing tool, as demonstrated in 
this project, provided a rationale for its use in future chronic disease and medication self-management 
studies. In the clinical setting, recommendations for clinical use of the tool should be based on its 
demonstrated clinical safety and effectiveness, data on neither of which is not currently available. For 
example, policy makers may be interested in seeing if such tool would have any effect on medication 
adherence, something that we were not able to show in this project and therefore could merit further 
investigations. Additionally, within the medication therapy management (MTM) process, the 
MedManager could be utilized as an additional tool to help address medication-related problems 
discovered during their medication review process.  
This project itself has also revealed a number of perceived barriers of existing medication self-
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management process that is to our knowledge has not been well-documented in the literature (Table 
10). These barriers should probably be taken into consideration in designing and implementation of 
future self-management interventions. It is also important to realize that chronic disease self-
management is a life-long process in which patients may encounter barriers in many other self-
management tasks besides medication taking and to recognize the importance of patient self-efficacy in 
performing theses tasks. Interventions designed to improve self-management, whether through 
education or introduction of innovative tools, should continue to make enhancing self-efficacy a main 
objective.  
 
VI. CONCLUSION 
In conclusion, we believed the MedManager was perceived as helpful to a number of our participants. 
This was supported by the observed utilization of the MedManager components at follow-up and the 
perceived benefits of the MedManager over existing organizing systems as reported by enrolled 
participants. Those with relatively complex medication regimens but without an effective storage 
system were seen as likely utilizers of the tool. Future research or marketing activities that seeks to 
maximize the impact of the MedManager or similar tools should consider including these patient 
populations in their studies. 
In addition to other existing medication management strategies such as pillboxes and blister packs, a 
medication organizing tool such as the MedManager represents another option to further assist patients 
with managing their medications and chronic conditions at home. Additionally, the tool’s portability that 
allows patients to quickly and conveniently carry medications outside the home could be beneficial in 
cases of emergency, while on traveling trips or to the hospitals as seen in a number of our participants. 
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Moreover, the enthusiasm observed in a number of enrolled participants at follow-up suggested that 
the tool could provide additional motivation and encouragement needed for some patients to start 
taking steps to better manage their medication regimens and chronic conditions.  
All of our participants lived in small towns or rural areas of Ontario. Compared to their urban 
counterparts, chronic disease self-management may be more important in rural communities for many 
reasons. Preventative care is less available in rural towns, and rural areas tend to have fewer primary 
care physicians and specialists. Additionally, rural residents may be less educated about their chronic 
conditions (e.g. due to lower levels of formal education).23 Consequently, efforts to encourage and 
enhance self-management for rural residents including making self-management education programs 
and self-management aids such as the MedManager available to rural residents may help address these 
disparities.  
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Appendix 3: Pre-Production Pharmacist Survey Sample 
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Appendix 5: Medication List Template 
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Appendix 6: Screening Survey  
 
EVALUATING THE USABILITY OF A MEDICATION ORGANIZING TOOL ON 
MEDICATION MANAGEMENT AT HOME SURVEY 
  
  
Part I: 
  
1. Please select your age group: 
  □ <40     □ 40-49    □ 50-59    □ 60-69 □ >69 
  
2. Gender 
  □ Male 
  □ Female 
  
3. Which city do you live in?  __________________________ 
  
  
4. How did you hear about this study?  ________________________ 
  
  
5. How many chronic medications are you currently taking? 
(Chronic medications are those you will be taking for a long period of time such as blood pressure, 
blood sugar, or cholesterol medications) 
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   □ <3    □ 3-5      □ 6-8      □ >8 
6. How many doses of medication do you take each day? 
       Morning    Afternoon  Evening    Bedtime 
#of doses: _____      ______     ______     _____ 
7. Have you been diagnosed with any of the following chronic conditions: (check all that 
applies) 
   □ High Blood Pressure 
   □ Diabetes 
   □ High Cholesterol 
   □ Heart Failure 
   □ Epilepsy 
   □ Others (please specify) ______________________ 
  
 
8. Does any of the following apply to you? 
   □ Take blood thinner medication 
   □ Have some degree of cognitive impairment 
   □ Impaired vision/difficulty seeing 
   □ Dexterity problems 
   □ Language difficulties 
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9. Do you take any of the following medications (check all that apply) 
   □ Warfarin 
   □ Anti-seizure medications 
   □ Mood stabilizers 
   □ Digoxin 
  
  
10. On average, how many times per week do you forget to take your regular medications? 
   □ 0-1   □ 2-4    □ 5-7  □ 8-10   □ >10 
  
  
11. Where do you store your medications? (check all that applies) 
   □ Kitchen     
   □ Bedroom     
   □ Bathroom    
   □ Others (please specify) ____________________________ 
  
  
12. Do you keep a list of your current medications? 
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   □ Yes        □ No 
  
  
13. Do you use a pillbox or blister pack? (check all that applies) 
  □ Pillbox 
  □ Blister pack 
  □ Neither 
  
14. Do you have any difficulties reading the medication names and instructions as printed on 
prescription vials? 
   □Yes         □No 
Please specify: _________________________________ 
  
  
15. How many pharmacies do you use to pick up your medications? (fill in the blank) 
   
 ____________ 
  
  
16. How many office visits did you have last year? (fill in the blank) 
  
  _____________ 
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17. When you go to your doctor’s appointment, do you bring any of the following with you? 
 □ My medications 
 □ My medication list 
 □ My list of questions for my doctor 
 □ Other (please specify) ________________ 
`  
  
  
18. Do you take readings of any of the following? (check all that applies) 
    □ Blood pressure 
    □ Fasting blood sugar 
    □ Weight 
    □ INR 
    □ Other (please specify) 
  
  
   Please provide the usual reading of each in the space below if remembered: 
Blood Pressure: ___________  
Fasting Blood Sugar: ____________ 
Weight:  ___________ 
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INR:  ___________ 
  
  
  
  
Part II: Please answer these Yes/No questions 
  
1. Do you ever forget to take your medicine? □ Yes / □ No 
  
2. Are you careless at times about taking your medicine? 
□ Yes / □ No 
  
3. When you feel better do you sometimes stop taking your medicine? □ Yes / □ No 
  
4. Sometimes if you feel worse when you take the medicine, do you stop taking it? □ Yes 
/ □ No   
  
5. It is easy for me to take my medicine on time. □ Yes / □ No    
6. It is easy to remember to take all my medicines.□ Yes / □ No      
  
7. It is easy for me to set a schedule to take my medicines each day.   □ Yes / □ No       
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8. It is easy for me to take my medicines every day. 
□ Yes / □ No 
  
9. It is easy for me to ask my pharmacist questions about my medicine.  □ Yes / □ No  
  
10. It is easy for me to understand my pharmacist’s instructions for my medicine. □ Yes / □ 
No    
  
11. It is easy for me to understand instructions on medicine bottles.   □ Yes / □ No  
  
12. It is easy for me to get all the information I need about my medicine.   
□ Yes / □ No    
  
  
  
 
 
Part III: 
  
Please fill out the contact form below if you are interested in evaluating the “MedManager” 
tool (pictures attached) designed to help simplify medication management at home. 
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Name …………………………………………………………………………………………. 
Address ……………………………………………………………………………………… 
  
Contact phone number …………………………………………………………….. 
Email (optional) ………………………………………………………………………….. 
  
  
  
  
*** Due to the limited number of the tools available and to best evaluate the project objectives, we limit 
enrollment to participants who meet one or more of the following criteria: 
  
-Taking 5 or more chronic medications 
-Take 12 or more doses per day 
-Have 3 or more chronic conditions 
-Difficulty with remembering to take medications 
-Taking the following medications (Warfarin, anti-seizures medications, Mood stabilizers, Digoxin) 
-Vision problem, dexterity problem (arthritis, etc.), mild cognitive impairment or language difficulties.*** 
  
  
  
  
  
Thank you very much for taking your time to complete this survey and your interest in this 
project! 
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  Appendix 7: The Morisky Scale 
  
  
Do you ever forget to take your medicine? Yes / No 
Are you careless at times about taking your medicine? Yes / No 
When you feel better do you sometimes stop taking your 
medicine? 
Yes / No 
Sometimes if you feel worse when you take the medicine, do you 
stop taking it? 
Yes / No 
  
  
 Interpretation: 
 Score 1 point for every YES answer 
o 0 points = high adherence 
o 1-2 points = intermediate 
o 3-4 points = low adherence 
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Appendix 8: Follow-up Session Observation and Interview Guide 
 
Picture of the MedManager? 
 
 Categories Current system  MedManager 
feedback 
1 Medication List 
          ⠎ Yes 
          ⠎ No 
          ⠎ Picture 
 
 
Description: 
 
 
Advantage: 
 
 
Disadvantage: 
 
 
Comments 
2 Medication Storage 
 
Description: (Locations) 
 
 
Advantage: 
 
 
Disadvantage 
 
 
Comments 
3 Adherence Aid Description: Comments 
131 
 
         ⠎ Pill Box 
         ⠎ Blister Pack 
 
 
Advantage: 
 
 
Disadvantage: 
 
 
4 Clinical Tracking 
System 
           ⠎ Blood Pressure 
           ⠎ Blood Sugar 
           ⠎ Weight 
           ⠎ Others 
(Specify) 
 
               Pictures? 
Description: 
 
 
Advantage: 
 
 
Disadvantage: 
 
 
Comments 
5 Communication 
strategies with 
healthcare team 
(any difficulties in 
communication with 
healthcare team a.k.a 
MDs or pharmacists) 
Description: 
 
 
Advantage: 
 
 
Disadvantage: 
 
Comments 
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6 Any other existing 
problems/difficulties 
Description: 
 
 
Barriers to improve: 
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Appendix 9: Information Letter and Consent Form 
 
Information Letter 
EVALUATING THE USABILITY OF A MEDICATION ORGANIZING TOOL ON MEDICATION MANAGEMENT 
AT HOME 
Dear patient(s), 
My name is Tuan Phan, a Master’s student at the University of Waterloo - School of Pharmacy under 
supervision of Dr. Feng Chang, PharmD.  As part of my Master’s degree requirement, we are conducting 
a study titled “Evaluating the Usability of a Medication Organizing Tool on Medication Management at 
Home”. The first part of the study is a survey (attached) designed to provide us with insights on how 
patients manage medications at home. I would appreciate if you would complete the attached brief 
survey. Participation in the survey is completely voluntary and expected to take about 10-15 minutes of 
your time. Most of the questions will be multiple choices, and you can omit any question you prefer not 
to answer. Should you choose to participate, please seal completed survey in the provided envelope and 
deposit in the nearby drop box. Only the researchers will have access to the secure lockbox and survey 
forms. There are no known or anticipated risks from participating in this survey. 
As a survey participant, you may be eligible to participate in phase two of the study to test-use the 
MedManager, a medication management tool designed to help improve the way medications and 
medical information are organized (pictures attached at the end of survey). This phase is expected to last 
two months and I will schedule a home interview with you mid-way to obtain feedbacks on the 
usefulness of the tool. At the end of the study period, you will be invited to complete an evaluation 
questionnaire to help us determine the effectiveness of the tool on certain outcomes such as 
compliance, medication knowledge and communication with physicians. Your participation in this phase 
is also optional and voluntary. The tool will be provided free-of-charge as the manufacturing cost is 
underwritten by the owner, Dr. Harry Wingate III, MD.  
The study is in compliant with the University of Waterloo Information Security Policy. Identifiable 
information such as your name or contact information if ever collected will be treated as confidential 
and stored separately from other information. Data collected will be stored in a locked cabinet at the 
University of Waterloo for 2 years. More information on the Policy can be found at the following web 
address: http://uwaterloo.ca/secretariat/policies-procedures-guidelines/policy-8 
This study has been reviewed by and received ethics clearance through a University of Waterloo 
Research Ethics Committee. The Director of Office of Research Ethics, Dr. Maureen Nummelin, can be 
contacted at 519-888-4567 ext. 36005 or by email at maureen.nummelin@uwaterloo.ca. If you have any 
questions about this study, I can be reached at 519-888-4567 ext. 21390 or by email at 
t4phan@uwaterloo.ca.  My faculty supervisor, Dr. Feng Chang can be reached at 519-888-4567 ext. 
21321 or by email at feng.chang@uwaterloo.ca.   
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Thank you in advance for your interests in this study.  
Sincerely, 
Tuan Phan - 2014 MSc. Candidate in Pharmacy Practice at University of Waterloo-School of Pharmacy 
 
CONSENT OF PARTICIPATION IN THE STUDY  
“EVALUATING THE EFFECTIVENESS OF A MEDICATION ORGANIZING DEVICE ON MANAGING 
MEDICATIONS AT HOME” 
By signing this consent form, you are not waiving your legal rights or releasing the investigator(s) or 
involved institution(s) from their legal and professional responsibilities. 
I have read the information presented in the information letter about a study being carried out by Tuan 
Phan, MSc. student under direction of Dr. Feng Chang at the University of Waterloo-School of Pharmacy. 
I have had the opportunity to ask any questions related to this study and received satisfactory answers 
to my questions and any additional details I wanted. I am aware that I may withdraw from the study 
without penalty at any time by advising the researcher(s) of this decision and that in the case of early 
withdrawal, I would still be given the option to keep the tool, and data obtained from my participation 
may or may not be used in the study result. I further understand that I can contact the student 
investigator by phone at 519-888-4567 ext. 21390, by email at t4phan@uwaterloo.ca and the Faculty 
Supervisor, Dr. Feng Chang at 519-888-4567 ext. 21321 or feng.chang@uwaterloo.ca with any concerns 
or questions during the study period. 
This project has been reviewed by, and received Ethics Clearance through the University of Waterloo 
Research Ethics Committee. I was informed that if I have any comments or concerns resulting from my 
participation in this study, I may contact the Director of Office of Research Ethics, Dr. Maureen 
Nummelin at 519-888-4567 ext. 36005.  
With full knowledge of all foregoing, I agree, of my own free will, to participate in this study.  
  
……………………………………………………. 
Please Print Name 
 
……………………………………………………. 
Signature of Participant 
  
……………………………………………………. 
Date 
